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This study examines social factors associated with the disproportionately higher 
incidence of Alzheimer's disease in the African American population. Ninety 
participants were selected for the study utilizing non-probability convenience sampling. 
The survey participants were composed of primary care givers of Alzheimer's clients. 
The findings of the study indicated that socio-economic factors were a significant 
variable in the diagnosis of Alzheimer's' disease. Respondents 65.9% reported that 
participation in research was not equally shared by all ethnicities. The results of the study 
revealed that 56.8% of respondents allowed patients to remain in the home due to support 
of other family members. The finding of access to health care was measured by 
information on medication and health care alternatives being provided to the care giver at 
the time of the diagnosis. Respondents (61.2%) reported no information given at the 
time of the diagnosis. The research findings related to stressors of caregivers of 
Alzheimer's patients were not found to be significant. 
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CHAPTER I 
INTRODUCTION 
Alzheimer's is a progressive, degenerative disease of the brain, and the most 
common form of dementia. Alois Alzheimer, a German pathologist (1 864-1 91 5), 
discovered Alzheimer disease in 1907. Many years passed before the American Medical 
Association, Diagnostic and Statistical Manual of Mental Disorders accepted and applied 
this diagnosis to clients in the United States. Initially this disease was predominantly 
diagnosed among Jewish immigrants. There were many myths as to the causes of the 
disease. One such myth was the association of traces of aluminum on the brain of the 
Jewish population in Germany. The brains of Jews were autopsied after death. It was 
noted that a large number of those autopsied showed traces of aluminum in the cerebral 
cortex. It was also noted that many of those that were autopsied had endured the 
Holocaust. Due to the diagnosis of Alzheimer's disease in the Jewish population, many 
of the early studies focused on this ethnic group. During autopsies there were noted 
changes in brain configuration and lost of fluids that were needed to carry electrical 
impulseslsignals to different parts of the body to initiate appropriate responses. There 
was also an obvious change in the size and weigh of the brain of those autopsied 
(Brookmeyer 2007). 
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Much has changed and new scientific findings and empirical research has aided in 
the early diagnosis and treatment of the disorder; however Alzheimer's disease is now 
the fourth leading cause of death in adults. It is estimated that 4.5 million Americans and 
eight million more people worldwide have the disease. The biggest risk factor associated 
with this disease is age: however age factors, alone, are not the single most known cause 
for the diagnosis of Alzheimer's disease. Studies in genetics have shown that certain 
diseases predispose many patients to the diagnosis. Those diseases are usually vascular 
diseases such as hypertension, diabetes and high cholesterol. Other research on 
Alzheimer's disease points to the value of diagnosing the disease prior to progression to 
stages two and three. Early detection of Alzheimer's disease decreases the cost of care 
to the client and society, improves the quality of life to the client, and associated stress to 
the caregiver. Detection at the pre-clinical stage or the Early Phase of Alzheimer's 
disease in the African American population is the desired goal (Sampson 2004, Hoyt 
1999, Bird 1989). 
The three stages in the progression of the disease process as given in the 
Diagnostic and Statistical Manual of Mental Disorders are: 
1. The Preclinical Stage is marked by very mild problems with memory, speed of 
processing and confrontation naming. The general cognitive abilities remain 
intact, however neuropathology has begun in the brain. 
2. The Early Phase is best noted by memory problems. The patient begins to repeat 
questions with forgetfulness of short-term memory issues. Because the patient has 
periods of memory where they sense that something doesn't "$el right" they 
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withdraw and often become depressed as gradual impairment in advanced living 
skills (i.e., activities of daily living) commences. 
3. In the Moderate to End of Life Phase, profound cognitive problems take place. 
Aphasia, the inability to communicate through speech, written or signs, are the 
furtherance of brain dysfunction. Aphasia may be considered complete or total if 
both the sensory and motor areas of the brain are involved. When Agnosia 
occurs, which is the loss of comprehension of auditory, visual or other sensations, 
the patient is no longer able to conceptualize what is heard, seen or felt. The 
gradual loss of basic life care abilities occurs when the patient becomes apraxic. 
Apraxia is the inability to perform purposeful movements, although there is no 
sensory or motor impairment with the patients' condition (DSMIII-R). 
Although Alzheimer disease was described 100 years ago, the preponderance of 
knowledge of the disease has mostly accumulated since the 1970's. The dramatic 
advances in research during the last three decades propelled the disease from near 
obscurity to the forefront of modern social, psychological and biomedical science. The 
remarkable study in the field of Alzheimer disease is reflected in the number of 
investigators, publications and funded projects. Multiple studies have created an 
atmosphere of optimism about the aspect of discovering effective interventions to delay 
the progression of the disease. The National Institute on Aging initiatives to promote 
interdisciplinary research programs by creating a nationwide network of collaborating 
investigators and a research infrastructure/resource influenced the pace of progress 
(Khachaturian 2007). 
In 2006, the worldwide prevalence of Alzheimer disease was 26.6 million. By 
2050, the prevalence will quadruple, by which time 1 in 85 persons worldwide will be 
living with the disease. It is estimated that about 43% of prevalent cases will need a high 
level of care, equivalent to that of a nursing home. If interventions could delay both the 
disease onset and progression by a modest one year, there would be nearly 9.2 million 
fewer cases of the disease in 2050 (Brookmeyer 2007). 
Alzheimer's disease in the U.S. population is a devastating disorder that is often 
unrecognized or misdiagnosed in its early stages. Despite the current lack of 
unequivocally effective treatment, recognition of early-stage dementia may offer 
substantial benefits. At present there is no cure for the disease only preventive 
measurements to assist the patient with comfort measures and maintenance of memory 
functioning via medication therapy. The education of the caregiver and increased 
opportunities of African Americans to become a part of research studies may improve 
access to health care and improve opportunities to gain access to medications and 
decrease stressors on the caregiver (Brookmeyer, 2007). 
Statement of the Problem 
To overlook the cost on society of Alzheimer's disease is one atrocity that our 
society cannot bear. To date 75% of all cost for patient care is paid by the families of the 
Alzheimer's patient. Half of all nursing home residents have a diagnosis of Alzheimer's. 
The cost for nursing home care per year is $42,000 and can exceed $70,000 per patient. 
The average lifetime coast per patient is $1 74,000. Alzheimer's disease is the third most 
expensive disease in the United States, after heart disease and cancer (Bloom, 2003). 
To meet the mission of the Alzheimer's organization, "...to eliminate 
Alzheimer's disease through the advancement of research: to provide and enhance care 
and support for all affected: and to reduce the risk of dementia through the promotion of 
brain health"; and the vision ". ..a world without Alzheimer's disease" we must look at 
factors that affect early detection and treatment from a social perspective (Alzheimer 
Fact Sheet, 2007). 
"Baby boomers" are the largest segment of the U. S. population. This age group 
is rapidly approaching the age for first onset diagnosis. Unless effective methods for 
prevention and treatment are discovered Alzheimer's will reach epidemic proportions. 
Based on today's progression rates, of diagnosis of the disease, it is likely that in fifty 
years from today the disease will afflict 14 million Americans if prevention or cures are 
not discovered. The 2006 population was 299,398,485 with greater than 10.1 % over the 
age of sixty-five. The percentage of African Americans' in this population is 12.4% and 
Caucasians 73.9% (American Community Survey, 2006). With the aging of the African 
American population, the expenditures on health care for the diagnosis of Alzheimer's 
disease will reach epidemic proportions. The global burden of Alzheimer's disease 
without early diagnosis, treatment and appropriate medication regimes when necessary 
will cost billions of dollars (Bruton, 2007). 
Disease progression is an important consideration in assessing the social, 
psychological, and financial burdens to the African American population and society as a 
whole. Delaying the disease onset into stages two and three by an average of two years 
would decrease the worldwide prevalence of Alzheimer disease by 22.8 million persons. 
This decrease in diagnosis would lead to a decrease burden on society and the family 
members of all races (Brookmeyer, 2007). 
Today the diagnosis of Alzheimer's disease is striking African American's who 
are more susceptible to the "brain-wasting" condition than any other group of Americans. 
Stephanie Johnson a research associate at Duke University Medical Center's "Bryan 
Alzheimer's Research Center" states "...dementia is anywhere from 14 percent to 100 
percent more prevalent among African Americans." According to the 2002 report by the 
Alzheimer's Association, 65 percent of African American Medicare beneficiaries have 
hypertension compared to only half of the white beneficiaries. And Blacks have a 60 
percent higher risk for type 2-diabetes than do whites (Type I1 diabetes is insulin 
dependent diabetes). These are the vascular diseases that lead to an increase prevalence 
of the diagnosis of Alzheimer disease in the African American population (Johnson, 
2007). 
These statistics in health care highlight that there is a significantly greater number 
of African American's who are at a greater risk for vascular diseases such as high blood 
pressure, diabetes and high cholesterol than other populations. Though these medical 
diagnoses may increase the risk of African American's, being diagnosed with 
Alzheimer's diseases it does not include social factors that are germane to the African 
American population. What medial statistics fail to capture in their hypothesis is the 
social factors leading to late diagnosis of Alzheimer's disease such as caregiver support 
and services, lack of access to medication and services, and the lack of African 
American's participation in research. This lack of representation may be associated with 
less access to medical care. This could lead to late diagnosis when the disease has 
progressed to a serious stage. The socioeconomic status as well, that may keep poor 
African Americans from the best health care. For many older Americans possibly the 
Tuskegee study still breeds' distrust for the medical association (Washington, 2006). 
Purpose of the Study 
The purpose of the study was to explain whether clients with Alzheimer's disease 
in the African American population had a higher incidence of the diagnosis due to social 
factors. The study was designed to explain social factors leading to the diagnosis of 
Alzheimer's disease in the African American population in five areas that included the 
socio-economic status, participation in research, caregiver knowledge and support, access 
to health carelmedication and caregiver stressors. The participants of the study were the 
caregivers of clients diagnosed with Alzheimer disease. 
Research Questions 
The research questions of the study were as follows: 
1. Is there a relationship between socio-economic status and the diagnosis of 
Alzheimer's disease? 
2. Is there a relationship between African American participation in research and 
lack of trust in the medicallresearch field? 
3. Is there a relationship between institutionalization of the client with Alzheimer 
disease and caregiver knowledge and support? 
4. Is there a relationship between the late diagnosis of Alzheimer disease in the 
African American population and the access to health carelmedication? 
5. Is there a significant relationship between caregiver stressors and caring for the 
Alzheimer relative? 
Hypotheses 
The null hypotheses for the study were as follows: 
1. There is no statistically significant relationship between low socio-economic 
status in the African American population and the diagnosis of Alzheimer's 
disease. 
2. There is no evidence of a relationship between African American participants in 
research and lack of trust in the medicalhesearch field. 
3. There is no relationship between institutionalization of the client with Alzheimer 
disease and the caregiver knowledge and support. 
4. There is no statistically significant relationship between the late diagnosis of 
Alzheimer's disease in the African American population and the access to health 
carelmedication. 
5. There is no statistically significant relationship between caregiver stressors and 
caring for the Alzheimer diseases relative. 
Significance of the Study 
With the disproportionately higher incidents of Alzheimer's disease among 
African Americans, it is imperative that studies conducted include African Americans in 
research, and focus on the influence of social factors contributing to the higher incidence 
of this diagnosis. Historically, members of minority populations have been 
underrepresented in clinical trials. There are many difficulties associated with 
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enrollment of minority individuals in research studies ands clinical trials. Cultural and 
language barriers must be overcome, and ways to inform individuals of the studies and 
trials available and their potential benefits for improvements in health must be found 
(Manly, 2005). 
African Americans represent 12.4% of the U.S. population with 8.6% over the 
age of sixty, while Caucasians represent 73.9% of the population with 84.3% over the 
age of sixty. The African American represents a small portion of the U. S. population but 
has a higher incidence of Alzheimer disease diagnosis. Between 1946 and 1964,76.2 
million babies were born and were called the "Baby Boomers." This population is 
quickly becoming the generation that will inherit the diagnosis of Alzheimer's disease 
(U.S. Census Bureau, 2000). 
This study purports to shed some light on social factors leading to the 
disproportionally higher incidence of Alzheimer disease in the African American 
population. It is therefore of great significance to demonstrate with these data whether 
social factors influence the disproportionally higher incidence of Alzheimer disease in 
the African American population. 
CHAPTER I1 
REVIEW OF THE LITERATURE 
The purpose of presenting this review of the literature was to lay a scholarly 
foundation in order to establish the need for this study. This chapter is a review of the 
current literature on the recent efforts to improve culturally appropriate health care 
delivery to minority populations diagnosed with Alzheimer's disease. The review 
covers the development prevention and intervention for healthy aging that is appropriate 
for the African American population. 
Historical Review of Alzheimer's Disease 
The study of Alzheimer's began in 1907 in Germany when the Jewish population 
began to have difficulty with recall and inability to maintain life skills. Today the spread 
of this disease has effected all populations. Few well-conducted studies have been 
utilized on the differences among population groups. The general studies have 
concluded African Americans and Hispanics have a higher risk than Caucasians for the 
diagnosis. In similar research it was noted that Alzheimer's disease occurs less 
frequently in Native American Crees and Cherokees and Asians than in the general 
American population ( NIA 2007). 
There are myriads of literature regarding Alzheimer's disease, treatment and 
causes. Some consider Alzheimer's to be a natural part of the aging process. Other 
theorists speculate on five areas that warrant further medical research. The Chemical 
Theory, the Toxic Chemical Excess, the Auto-immune, Slow Virus and the Blood Vessel 
Theories were all a part of earlier research studies (Carson & Arnold, 1999). 
The Chemical Theory of neurotransmitters focuses on the diminishing of these 
transmitters in the brain and is associated with the diagnosis of Alzheimer's. It was 
noted that decreases in functional abilities were related to the decrease in 
neurotransmitters. These transmitters did not relay information to organs and body parts 
of the patient in their environment, in order to obtain appropriate functioning or response 
from the patient (Carson & Arnold, 1999). 
The Toxic Chemical Excess Theory has as its' focus large deposits of aluminum 
being found on the autopsied brains of patients diagnosed with Alzheimer's. This excess 
of aluminum interrupts the flow of transmitters to assist with the well being of the patient 
and decreases the functioning of the patients' ability by ultimately poisoning the brain. 
This theory was one of the first theories used in the diagnosis of Alzheimer's disease in 
Germany, by Alois Alzheimer. Little was known in 1907 of the role that the immune 
system would play in the diagnosis of Alzheimer's (Carson & Arnold, 1999). 
The Autoimmune Theory focuses on the immune system that serves to protect the 
body from harmful invaders. The system turns on itself and begins to attack its' own 
tissues, and then produces antibodies that attacks its' own cells. This theory is not 
considered a virus but decreases brain cells as the antibodies destroy brain tissue. The 
Slow Virus theory has been identified an associated with human virus. 
The Slow Virus Theory is a slow-acting virus that has been identified in brain 
disorders similar to Alzheimer's (i.e. Parkinson's). This virus is found in spinal fluids of 
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those living, and allows for medicinal treatments to decease the signs and symptoms of 
the disease process. The last two theories, the Genetic and the Blood Vessel theory are 
more aligned with social and cultural factors affecting various populations (Carson & 
Arnold, 1999). 
The Blood Vessel theory has as its' focus the blood supply to the brain. The three 
most common vascular diseases to affect brain activity are hypertension, high cholesterol 
and diabetes I. These three diagnoses are highest among the African American and 
Hispanic populations; which predisposes these populations to the diagnosis of 
Alzheimer's at a higher incidence than other populations. Along with this theory is the 
Genetic theory which links diagnosis to inherited traits. 
The Genetic theory is associated with the production of apolipoprotein. This 
theory is associated with a mutation on chromosome 14, which accounts for 10% of the 
Alzheimer's cases. Mutations on chromosomes 1 and 21 are linked to late-onset of 
Alzheimer's. These chromosomal studies are not significant for Afi-ican Americans. 
These chromosome mutations are significant genetic studies applicable to Caucasians, 
and yet the diagnosis of Alzheimer's is more prevalent in the Afi-ican American 
community (Carson & Arnold, 1999). 
Genetic studies applicable to African Americans have as their primary focus 
genetic links the most commonly found diseases in the African American population are 
high cholesterol, hypertension and diabetes. With the research focus of African 
Americans being that of genetic predisposition many social concerns warrant a different 
approach to the higher incidence of this disease among African Americans. 
National Policies on Alzheimer's Disease 
In 1965 the Older Americans Act, Medicare and the enactment of SSI, afforded 
major medical services for the older population. A huge portion of the federal budget 
was allocated to older persons, including the 29.4% of the 1990 federal budget ($341.4 
billion) consumed by two programs, Medicare and Social Security. The elderly still had 
problems associated with the consumer fees attached with the use of Medicare. The 
elderly were to pay 50% of their cost for services. As a result many older citizens 
divested their savings to obtain funds from the means-tested Medicaid program. Many 
older persons and their families were heavily burdened in 1992 when Alzheimer's 
disease became the fourth greatest killer of older persons (Jansson, 1997). 
Alzheimer's disease and related dementias present enormous demographic and 
financial challenges to society. Today, an estimated 4.5 million Americans, more than 
one in 10 persons over age 65 and nearly half of those over 85, have Alzheimer's disease. 
In the midst of a growing budget deficit, the federal government has decreased its 
commitment to biomedical research funding and programs that support individuals with 
Alzheimer's disease and now their caregivers are in jeopardy. Alzheimer's disease is just 
not another item in the budget; ... it is a national crisis in the making." Because age is a 
known risk for Alzheimer's disease, the demographics of our aging society demonstrates 
that decreasing funding for research and care in an attempt to reduce the deficits is 
penny-wise and pound-foolish" (National Public Policy, 2006). 
The fiscal year 2006 budget approved by Congress reduced funding for 
biomedical research for the first time in more than 30 years and the third time in the 
history of the Alzheimer's Association. Funding for Alzheimer's disease research 
declined by approximately $4 million dollars, an amount that may not appear alarming 
until it is considered alongside the projected growth in health care spending that 
Alzheimer's disease will cause if it is not brought under control. The Deficit Reduction 
Act passed by Congress in 2005 places additional financial restrictions on who can 
qualifl for Medicaid nursing home coverage, increasing the already heavy burden on 
family caregivers. In February 2006, President Bush released his 2007 budget proposal 
which further reduced the budget for Alzheimer's disease research, eliminated all of the 
federally funded Alzheimer's disease care programs and cut dollars for other programs 
that provided services to the frail elderly and their caregivers (National Public Policy, 
2006). 
Medicare Part A pays for hospital care, home healthcare, and hospice. Part B of 
Medicare pays for doctors' visits, out patient hospital care and other medial services 
requiring hospitalization. Part B of Medicare must be purchased for a monthly premium 
of $50.00. Medicare does not pay for prescription drugs for Alzheimer's, adult day care, 
board at assisted living facilities, or custodial care in nursing homes (U. S. Department of 
Health, 2003). 
Contemporary Review 
Recent empirical studies on Alzheimer's disease have focused on aspects of the 
disease process in relationship to physiological aspects of the disease process. 
Environmental and social factors such as: socio-economic status, African American's 
participation in research, caregiver knowledge, support and access to health care and 
medications and caregiver stressors may lend credence to the body of knowledge 
available. Social factors affecting the diagnosis of Alzheimer's disease in the African 
American population along with the rising numbers of Baby Boomers if not researched to 
the extent deemed necessary to decrease the highest diagnosis of Alzheimer's disease in 
the African American population may lead to astronomical cost to society (Manly, 2004). 
Socioeconomic Status 
Although numerous studies have documented the importance of socio-economic 
status (SES) to a variety of health outcomes, comprehensive measures of SES are not 
routinely collected in the Unites States. In addition, most SES data that are obtained are 
not reported. This data deficiency was highlighted at a recent federally-sponsored health 
conference on SES and has been noted by the National Committee on Vital Statistics. In 
both cases, the recommendation was for regular collection of SES data and for the use of 
SES variables in studies of differential health outcomes (Daly, et al, 2000). 
Despite growing awareness of the need for regular collection of SES measures, 
there remains little agreement on which SES measures should be gathered. One problem 
is that numerous measures of SES have been shown to affect health outcomes, e.g., 
occupation, education, and household income. Researchers have shown that these 
measures are not interchangeable, and that the impact of any particular SES measure on 
health varies across social groups, gender and age. Various measures of SES may 
summarize different components of overall health risk. A systematic evaluation of the 
explanatory power of various SES measure is required before an effective set of optimal 
indicators can be created (Daly, et al, 2000). 
Years of completed schooling are reported with reasonable ease and reliability 
and are a meaningful indicator of SES for most adults. Occupation has also been an 
indicator of SES and is useful for persons who have had labor force experience. Income 
has been more widely used as a measure of SES in studies in the United States than 
elsewhere. The income reflects the value of human wealth or capital. Several studies in 
both the United Sates and the United Kingdom found that indicators of wealth are related 
to health, independent of the more traditional indicators of SES (Daly, et al, 2000). 
According to Wilson et a1 in 2005 early life SES to incident of Alzheimer's 
disease, level of cognition and rate of cognitive decline in old age was examined. For up 
to ten years, 859 older catholic clergy members without dementia at baseline completed 
annual clinical evaluations as a part of the Religious Orders Study. The evaluations 
included clinical classification of Alzheimer's disease and detailed cognitive testing. At 
baseline, indicators of early life household SES level (e.g. parental education) and the 
county of birth were ascertained. SES features of the birth county (e.g. literacy rate) 
were estimated with data from the 1920 US census. Composite measures of early life 
household and community SES level were developed. In analyses that controlled for age, 
sex, education, higher household and community, SES levels in early life were associated 
with higher level of cognition in late life, but not with risk of Alzheimer's disease or rate 
of cognitive decline. The results suggest that early life SES level is related to level of 
cognition in late life but not to rate of cognitive decline or risk of Alzheimer's disease 
(Wilson, 2005). 
Another study assessed the relationship of three measures of SES status, 
education, occupational prestige, and income, to risk of incident clinically diagnosed 
Alzheimer's disease. This cohort study was performed over a period of four years in 
Boston Mass. A stratified random sample of community residents, sixty-five years or 
older and who were free of Alzheimer's disease at baseline were surveyed. Clinical 
diagnosis of probable Alzheimer's disease according to standard criteria, using structured 
uniformed evaluation was utilized. The results of the study using logistic regression 
revealed that fewer years of formal schooling, lower income, and lower occupational 
status each predicted risk of incident of Alzheimer's disease. The risk of Alzheimer's 
disease decreased approximately 17% for each year of education. The analysis using all 
three measures showed that the effect of education on risk for disease remained 
approximately the same, but the effect of the other two measures, occupational prestige 
and income, were somewhat less and did not attain formal statistical significance, 
compared with separate analysis of each measure. The study concluded that markers of 
lower SES predict risk of developing incident of Alzheimer's disease. The mechanism of 
the relationship was uncertain, but the possibility that it reflects unidentified and 
potentially reversible risk factors for the Alzheimer's disease deserves more 
consideration (Evans, 2007). 
Karp, et al., (2004) evaluated whether there was an association between low 
educational levels and increased risk of Alzheimer's disease and dementia. They 
assessed occupational-based SES. A cohort of 93 1 non-demented subjects, aged 
seventy-five years or older, was studied for three years between 1997 and 1993. A total 
of 101 incident cases of dementia, 76 involving Alzheimer's disease were detected. Less 
educated subjects had an adjusted relative risk of developing Alzheimer's disease of 3.4 
(05% confidence interval: 2.0,6.0), and subjects with lower SES had an adjusted rate 
relative risk of 1.6 (95% confidence interval: 1 .O, 2.5). When both education and SES 
were introduced into the same model, only education remained significantly associated 
with Alzheimer's disease. The combination of low education with high or low SES were 
associated with similar increased risks of Alzheimer's disease, but well educated subjects 
with low SES were not as high risk. Low SES at 20 years of age, even when SES was 
high at age 40 or 60 years, was associated with increased risk; however, this increase 
disappeared when education was entered into the model. This study concluded that the 
association between low education and increased Alzheimer's disease risk was not 
mediated by adult SES or SES mobility. This study suggested that early life factors may 
be relevant (Karp, et al., 2004). 
Participation in Research 
Flawed medical experimentation with African American's since the time of the 
plantation has played a pivotal role in the lack of participation in research. Historically 
African American's have been subjected to exploitative, abusive and involuntary 
experimentation at a rate far higher than other ethnic groups. This is neither a baseless 
fear of harm nor a fear of imaginary harm. The label of being paranoid is attached when 
African American's refuse to participate in research (Washington, 2006). 
Those who investigate the role of medical ethics and policy are attempting to 
analyze the aversion of African Americans to participate in research without 
understanding the history of the aversion. Researchers often focus on the Tuskegee 
Syphilis study without the many other experiments with Afiican American's. Some of 
the distrust dates back to the antebellum days of blood letting, the display of slave bodies 
by physicians, experimentation in the use of radiology treatments, and the Norplant in 
low economically disadvantaged communities. Researchers have exploited the African 
American population. This was the norm for much of our nation's history, when African 
Americans were commonly regarded as fit subjects for nonconsensual, non-therapeutic 
research (Washington, 2006). 
Trust is an important element of communication and many ethnic elders lack trust 
in health care professionals as well as the American health system. One of the most 
famous examples of why trust is lacking, is the ethnic elders involved in the Tuskegee 
study. The United States Public Health service tracked 399 African American men with 
untreated syphilis fiom 1932-1972. The research participants were untreated despite the 
discovery of penicillin in the 1940's. The research participants were not treated with the 
penicillin because the purpose of the study was to chart the natural history of syphilis. 
This violation of trust could very well lend credence to the limited numbers of African 
Americans in research. As the older population becomes more ethnically diverse, health 
professionals will need to become more knowledgeable about the cultural backgrounds of 
their clients to obtain subjects to participate Alzheimer's research (Washington, 2006). 
Green, et al., examined participation of adults (1 8 and older) who lived in 
Jefferson County, Alabama, to determine the effects of the Tuskegee Syphilis Study on 
African Americans' willingness to participate in health studies. They found that African 
Americans indicated less interest than white Americans in participating in health research 
or health promotion activities because of the Tuskegee Syphilis experiment (22% vs. 
lo%), and African American males reported less interest than white males (27% vs. 
1 1%). They concluded that the historical legacy of poor treatment by physicians had a 
major implication on researchers' ability to recruit research participants, especially 
African Americans (Green, et al., 1997). 
Research pioneered by Shavers, et al., focused on the relative absence of 
minorities in medical research. The relative absence of raciallminorities among medical 
research subjects received considerable attention because of recent government mandates 
for their inclusion in all human subject research. They examined racial differences in the 
prevalence of socio-cultural barriers as a possible explanation for the underrepresentation 
of African Americans in research (Shavers, et al., 2002). 
During 1998- 1999, a total of 198 residents of the Detroit Primary Metropolitan 
Area participated in a survey that examined impediments to participation in research 
studies. Chi square tests and logistic regression analyses were used to examine the 
association between race, issues related to trust of medical researchers, and the 
willingness to participate in studies. Results indicated that African Americans and whites 
differ in their willingness to participate in research. Racial differences in the willingness 
to participate in research were primarily due to the lower level of trust of the medical 
research among African Americans. African Americans were also somewhat less willing 
to participate if they attributed high importance to the race of the doctor when seeking 
routine medical care, believed that minorities bear most of the risks of research, and if 
their knowledge of the Tuskegee Study resulted in less trust in medical researchers 
(Shavers, et al., 2002). 
Participation of African Americans in research is required in order to answer 
many research questions correctly. It is important that normative studies include 
complete and accurate measurement of factors that not only underlie cognitive test 
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performance but are also the variables for which racelethicity serves as proxy. Jennifer 
Manly (2004) informs researchers ". ..in much research we are using measures that were 
originally developed by and for well educated Caucasians. Even the largest and most 
comprehensive normative sample would not improve the questionable construct validity 
of cognitive measures when used among African Americans." Despite recent and 
projected growth in racial and ethnic diversity within the population of the United States, 
few neuropsychological measures have been properly validated for use among ethnic 
minorities (Manly, 2004). 
Caregiver Knowledge and Support 
With the current aging of the population in the U.S. the number of those with 
Alzheimer disease is increasing rapidly, and along with it, the impact of the disease on 
society. The risk of Alzheimer's disease is four times higher for African Americans, and 
twice as high for Hispanics as for white Euro-Americans. Research is expanding both to 
prevent or delay the disease and to assist the caregiver in maintaining the patient in the 
home. More than 75% of those diagnosed with Alzheimer's disease are cared for in the 
home (Stanton, 2001). 
Estimates of the number of frail older people living in the community who need 
care giving assistance with activities of daily living (ADL's), such as shopping and 
bathing are estimated to range from 1.8 million to 7.6 million older people in the United 
States. It has also been estimated that there are 13.3 million informal caregivers of 
disabled older adults in the United States. Most informal caregivers are spouses and 
adult children, but other family members, friends, and neighbors also provide care 
(American Association of Retired Persons, 1999). 
When a loved one begins to develop the early signs of Alzheimer's disease it is 
alarming to them and the caregiver. Alzheimer's disease attacks the central organic core 
of the being, the brain. The changes and destruction to the brain fundamentally changes 
who they are and how the caregiver interacts with them. Personality changes and 
increasing dependence on family members, the gradual but increasing memory loss and 
changes in relationship dynamics are difficult to deal with no matter how strong the 
relationship was prior to the onset of Alzheimer's disease. Even though a caregiver can 
understand the processes that are occurring, matching those changes and responding 
appropriately to the person with Alzheimer's disease requires not only patience, but 
skills, knowledge and support (Alzheimer's News Letter, 2007). 
Previous research focused on the association of knowledge level of the caregiver 
regarding dementia Alzheimer's disease, and institutionalization of a family member. 
Several factors influenced the decision. The study compared predictors of desire to 
institutionalize versus those who did not. Seventy-two caregivers completed the Desire 
to Institutionalize Scale (DIS) and several psychosocial measures, involving burden, 
dementia knowledge, self-efficacy, depression, health, and social support. The groups 
were then divided into "no desire for institutionalization" (No DI) and "desire for 
institutionalization" (DI). The results were that the DI caregivers had significantly higher 
burden, greater dementia knowledge, more family dysfunction, and decrease family 
support compared with No DI. Dementia knowledge was associated with higher desire to 
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institutionalize, suggesting that the knowledge and educational programs alone may not 
be helpful to delay institutionalization (Spitznagel, 2006). 
Another study researched the effects of knowledge of Alzheimer's disease with 
caregivers and the consequences of such knowledge. The study measured two items the 
amount of knowledge that the caregivers possessed. The second explored possible 
correlates of knowledge of Alzheimer's disease. One hundred and one caregivers 
participated in the study. Participants' were given a 30 item test which consisted of 15 
multiple choice items and 15 true false items. The caregivers answered and average of 
46 percent of the items correctly. Female caregivers answered more questions correctly 
compared to male caregivers. It appears that education about Alzheimer's disease is 
needed, especially in caregivers of patients diagnosed with possible or probable 
Alzheimer's (Hicks, 2004). 
Family caregivers of older adults are faced with a variety of emotional and 
behavioral difficulties, such as dealing with persistent, repetitive questions, managing 
agitation and depression and monitoring hygiene. Although professional and 
governmental organizations have called for the creation of community-based education 
and support programs, most caregivers continue to receive little or no formal instruction 
in responding to these challenges (Hicks, 2004). 
In yet another study related to lack of social support and stressors on the 
caregiver, Haley, et al., found that family caregivers of patients with Alzheimer's disease 
commonly have high levels of psychological distress. African American caregivers often 
report less depression than white caregivers, but the process underlying this difference 
was poorly understood. With the use of a stress model, 123 white and 74 African 
American family caregivers of patient with Alzheimer's disease and other progressive 
dementias were studied. African American caregivers appraised patient problems as less 
stressful and reported higher self-efficacy in managing caregiver problems and less 
depression than did white caregivers. White and African Americans' also differed 
significantly in coping responses but not in social support. Caregiver responses and race 
did not affect wellbeing through direct paths, but they were mediated by effects for 
appraisal, social support, activity, and coping (Haley, et al., 1996). 
In a qualitative analysis, 5 1 participants responded to open-ended questions 
regarding the experiences of being family caregivers for a loved one affected with 
Alzheimer's disease. The participants' had been in the caregiver role for more than eight 
years. Results indicated that they were adapting successfully or unsuccessfully to the 
caregiver role experiencing initial caregiver burden finding relief in social support when 
available, and long term positive change. Memories and feelings were strong about 
individuals and institutions that had been helpful or indifferent many years earlier as the 
caregiver struggled to cope with their unplanned predicament (Karlin, et al., 200 1). 
In a telephone interview conducted in 2007, research documented notable 
differences in knowledge, awareness, and cultural beliefs about Alzheimer's disease 
among groups defined by race and ethnicity. The study was conducted to assess racial 
differences in knowledge and attitudes about Alzheimer's disease among a national 
sample of adults. Data fi-om 1176 adults aged 35 years and over (48.6% white, 25.7% 
African American, and 25.8% Hispanic) were obtained, via telephone interview in this 
study. Although some notable group differences defined by racelethnicity were 
observed, more similarities in patterns of responses were discovered than expected. 
African American and Hispanic respondents were significantly more likely to believe 
that Alzheimer's disease is a normal part of aging, but were more optimistic about future 
advances in research than white participants. Compared with white and African 
American respondents, Hispanics were more likely to report feeling well prepared for 
handling a diagnosis of Alzheimer's disease in a family member. Overall, the results 
suggest that misconceptions about Alzheimer's disease remain among large segments of 
the population that Alzheimer's disease remains a source of significant concern, and that 
continued efforts are need to educate caregivers and the public about this disease process 
(Connell, et al., 2007). 
Access to Health Care and Medications 
Early identification of Alzheimer's disease provides opportunities to initiate 
treatment that may slow a patient's disease progression until the family member can 
connect and access health care providers and supportive services. As the need for 
services for people with Alzheimer's disease grows, the benefits of early intervention 
becomes clear, it has become important to understand what factors may improve access 
to services for people with early-stage dementia (Pratt, 2005). 
In a study, 30 key professionals were interviewed about access to services for 
people with early stage Alzheimer's disease in order to explore how different models of 
access were reflected in their own understanding. When articulating the reasons they 
thought needs were unmet, participants focused on the impact of the framework within 
which services are delivered. The findings highlight the importance of considering 
relationships and socio-contextual factors, such as the impact of the framework of service 
delivery, when attempting to understand variations in access to services. In order to 
improve access to services, it will be necessary to move beyond addressing individual 
factors relating to access, and to consider the impact of the framework for service 
delivery and the relationships that influence contact with services (Pratt, Claire & 
Kirchner, 2006). 
A cohort study of African American patients and their caregivers presenting at a 
suburban memory assessment clinic and were diagnosed with probable Alzheimer's 
disease were interviewed. Data was collected about the delay from noticing first 
Alzheimer's disease signs until recognition that a problem existed and delay from 
problem recognition until first physician consult. Median delays in caregivers' 
recognizing a problem and in consulting a physician were as long as seven years. Lack 
of physician contact is likely to be widespread in families caring for African American's 
with Alzheimer's disease. Intensive efforts are needed to connect African American 
families with physicians and to achieve more timely diagnosis of Alzheimer's disease to 
enable families to understand the illness, plan for patient safety, make long term care 
plans and gain access to health care services (Clark, et al., 2005). 
Although there is no cure for Alzheimer's disease there are a number of drugs that 
are available globally that can help slow cognitive deterioration. The aim of Alzheimer's 
disease medications is to improve cognitive ability to think, perceive, judge and 
recognize (Alzheimer's Fact Sheet, 2007). 
President Clinton underscored the need for a Medicare Prescription Drug Benefit 
plan in July 2000 in light of research prevention of Alzheimer's disease. He stressed 
". ..there must be a commitment to pursuing research possibilities equaled by our efforts 
to provide an affordable, meaningful, prescription drug benefit option for all Medicare 
beneficiaries in order to obtain present medications for Alzheimer's disease " 
(Whitehouse Backgrounder, 2000). 
Most low-income elderly and disabled persons lack coverage for important 
medications, resulting in unavoidable deterioration of health among those with chronic 
illnesses and use of expensive institutional services. Rapidly escalating drug cost, more 
restrictive drug coverage policies, and a dramatic increase in the population of elderly 
persons will exacerbate these problems. With the current budget surplus, as well as 
bipartisan concern about health care needs and public concern about drug costs and 
coverage, the Harvard Medical School in Boston, MA feels that it is time to act 
responsibly and aggressively. The recommendation is that a national replication of the 
best features of a state pharmacy assistance program in a federal-sate insurance program 
for low-income Medicare enrollees, either alone or in combination, with expanded 
Medicare coverage. Such a program would reduce the current inequitable situation in 
which the most vulnerable patients have the least access to medications, with serious 
medical and economic consequences (Soumerai & Ross-Degnan, 1999). 
There are five prescription drugs currently approved by the U.S. Food and Drug 
Administration to treat people with Alzheimer's disease. Treating the symptoms 
Alzheimer's disease can provide patients with comfort, dignity and independence for a 
longer period of time and can encourage and assist their caregiver as well. Mild to 
Moderate Alzheimer's disease is treated with Reminyl, Exelon, Aricept, and Cognex. 
To treat Moderate to Severe Alzheimer's disease, Namenda is used and may help the 
patient maintain the ability to go to the bathroom independently for several more months, 
a benefit for both patient and caregiver (Alzheimer's Disease Medication Fact Sheet, 
2007). 
The cost for Alzheimer's disease medication averages about $5.00 per day. 
Listed below are the average costs to the pharmacy. Aricept $142.00 per month, Exelon 
$134.00 per month and Reminyl $130.00 per month is the estimated average cost to the 
pharmacy prior to prescription filling fee. Namenda and Cognex bear a heavier monthly 
cost due to the new emergence of these drugs, which may be found in the neighborhood 
of $175-$250 per month prior to prescription filling fee, with no generics currently 
available for any of the medications listed above (Delagarza, 2003). 
A cross sectional survey, of a national sample of 4050 adults aged 50 years or 
older who use prescription medications for at least five chronic health conditions were 
surveyed. The primary outcome measure was patient report of being asked by a doctor or 
nurse in the prior 12 months whether the patient could afford the prescribed medications. 
The measures of prescription cost burden were cost-related underuse of medications, 
cutting back on other necessities to pay for medications, and worries about medication 
costs. Adjustment was made for patient income, education, racelethnicity, age, sex, and 
health status, number of prescribed medications, pharmacy benefits, and frequency of out 
patient visits, having a regular health care provider and sampling weights. In the 
weighed analysis, 16% of the respondents reported that they had been asked about 
potential problems paying for prescribed medications. Only 24% of the 1499 
respondents who reported one or more burdens from out-of-pocket medication costs 
reported being asked this question. After an adjustment was made for potential 
cofounders, patients who had cut back on medications use or other necessities to cover 
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payments were no more likely than other patients to be asked about the ability to pay for 
prescription medications. Concerns about medication, being a raciallethnic minority, 
taking seven or more prescription medications, and having no prescription coverage were 
independently associated with a greater likelihood of being asked about possible 
problems with prescriptions (Heisler, et al., 2003). 
It is widely recognized that the ability to pay effects physicians care, 
hospitalizations and medications. It has been hypothesized that persons with higher 
incomes and better health insurance coverage are more likely to medicate common health 
problems than those with lower incomes and less comprehensive coverage. A landmark 
study in 1998 surveyed 4,066 elderly Pennsylvania Medicare beneficiaries. These 
beneficiaries were asked to complete a mail survey on health insurance, income and 
medicine use for 23 common health problems. The relationship between ability to pay 
and medication decisions was analyzed using Poisson logistic regression models with 
covariates for socio-demographic characteristics and health status. The results showed a 
strong and consistent relationship in the hypothesized direction. 
Other things being equal, elderly persons with Medicare supplementation were 
between 6% and 17% more likely to use prescription medicine to treat their health 
problems than were persons with Medicare coverage alone. The elderly with annual 
incomes greater than $1 8,000 were 18% more likely to treat problems with prescription 
drugs than were persons with an annual income less than $6,000. This research 
concludes that economic factors appeared to play an important role in medication 
decisions by the elderly. The magnitude of the impact was sufficiently high so that it 
could have major negative consequences on the health of elderly persons who are poor 
and lack drug coverage (Stuart & Grana, 1998). Though President Clinton understood 
the need for Prescription Drug Benefit plan, healthcare utilization and access must 
become more culturally sensitive in order to increase utilization of services by African 
Americans. 
Research by George Rust (2004) utilized secondary data of 3,462 records of 
African American respondents to the 1999 Medical Expenditure Survey Household file. 
They concluded that there was a significant variation in the number of office visits, 
outpatient clinic visits, hospital discharges, and the number of days hospitalized and 
prescriptions filled among this population. There were three modifiable factors, poverty, 
insurance, and lack of a primary care physician as having a striking effect for African 
American patients. Barriers to utilization of services were noted as availability, 
accessibility and acceptability. 
Availability of services was linked to sometimes not being able to obtain a 
primary care physician where ethnic elders lived. Even more difficult was specialty care 
physicians in the areas where many African Americans reside. Accessibility was 
determined by the African American as available care but the inability to use or access 
services for a number of reasons measured were: lack of knowledge, distrust of the 
system, fear of punitive action, inability to deal with bureaucracy, assumptions by 
providers of lack of motivation or trust and transportation difficulties. Acceptability of 
the patient was linked as another barrier to access and utilization of services and was 
based on patients' satisfaction with having their expectations met. Acceptability was an 
aspect of access and utilization of services most affected by culture and the interaction 
between patient and provider performance. Trust needed to be developed between the 
provider and patient in order to gain access to services. In order to gain access and 
utilize services, indigenous networks for education and outreach must be formulated. 
Utilization of churches, temples, lay leaders and non-professional advocates can be 
utilized to increase access to medication and services for African Americans with 
Alzheimer's disease. 
Caregiver Stressors 
Some five million Americans care for loved ones with Alzheimer's disease at 
home, in nursing homes or assisted living facilities. Many caregivers feel isolated from 
family, fiends and their communities. Stress levels of caregivers rise as Alzheimer's 
disease symptoms grow and become more severe. Social support is needed to help bear 
not only the financial burden, but the psychological and social aspects of those diagnosed 
with Alzheimer's disease. Improving social support and reducing family conflict to help 
the caregiver withstand the hardships of care giving requires a multitude of social support 
systems. To help society and other family members understand the primary caregiver's 
needs and how to best become helpfbl may postpone the institutionalization of patients 
diagnosed with Alzheimer's disease (Fisher Center, 2006). 
Caregivers who lack sufficient or appropriate social support are often put under 
heightened stress. Family conflicts, isolation, loneliness further exacerbate the stress of 
the caregiver. While social support may not affect primary stress caused by Alzheimer's 
disease, it can change the caregivers' response to the illness. Feeling supported by 
social/community services and family can improve the psychological response to stress 
and boost the caregivers sense of well being. Caregivers can benefit from formal support 
by community services such as in home respite or day care programs for the patient, and 
support groups in conjunction with the informal support of family and friends 
(Alzheimer's Caregivers Fact Sheet, 2007). 
More than 80% of Alzheimer's caregivers report that they frequently experience 
high levels of stress, and nearly half say they suffer from depression. The National 
Family Caregiver Alliance terms caregiver depression as "...one of today's all-to-silent 
health crises". The alliance estimates that care giving spouses the ages of 66 to 96 who 
are experiencing mental or emotional strain have a 63% higher risk of dying than people 
the same age who are not caregivers (Abe1,2003). 
Caregivers often experience feelings of guilt, believing they are not doing enough 
to help. Spouses and adult children feel grief and loss except for being sudden, it spreads 
over years. Alzheimer's is a progressively worsening disease, but the rate of progression 
from mild to advanced stages can vary from three to 20 years. As the disease progresses, 
the loss of brain h c t i o n  itself will cause death unless the patient has one or more other 
serious illnesses (Health Link Fact Sheet, 2003). 
Financial strain from the disease process brings about problems that can also add 
to stress and depression. Caregivers will often give up paying jobs for the unpaid job of 
caring for the family member with Alzheimer's disease. Additional responsibilities are 
thrust upon them such as over seeing medication rkgime, taking on power of attorney 
along with living wills and advance directives that specify whether terminal patients 
should undergo extreme measures to keep them alive. In the book "The 36 Hour Day, 
Mace and Rabins made the first reference to caregiver stressors: 
As the patient's illness progresses and the person changes, you may 
experience the loss of a companion and a relationship that was important 
to you. You may grieve the way she use to be. We usually think of grief 
as an emotional experience that follows death. However, grief is a natural 
emotional response to loss and so it is a normal experience for people who 
love a person with a chronic illness (p. 209). 
Caregiver's of individuals with Alzheimer's disease are at an increased risk of 
mental and physical problems as a result of the strain that accompanies this role. Despite 
clear indications that caregiver grief and feelings of loss are normal, researchers did not 
begin to address the idea until late 1980's and mid 1990's. Two of the earliest 
researchers on this topic were Wasow and Coons. They indicated that the grief of 
caregivers of individuals with Alzheimer's disease often remained undetected by society. 
Not recognized as normative behavior, grief and loss were combined with feelings of 
stigma which was often associated with the disease (Wasow & Coons, 1987). 
In 1999, Boss coined the term "ambiguous loss" to define grief that has no clear 
starting point and no clear ending point. This type of grief experienced by Alzheimer's 
disease caregivers is ambiguous because the care recipient is still physically present, but 
cognitively not the same person. Boss argued that the depression commonly noted in 
caregivers of individuals with Alzheimer's disease probably has more to do with the 
ambiguity of their loss than their heavy work load. The feeling of being out of control 
commonly associated with ambiguous losses can lead to increase family conflict; 
problematic communication patterns an obsession with the day to day activities of caring 
for the patient (Boss, 1 999). 
There is also grief at different stages of the disease. The profound feelings of 
grief expressed following the diagnosis of Alzheimer's disease. Grief becomes stronger 
when the patient no longer recognizes the caregiver which often occurs in the middle 
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stages of the disease progression. Other researchers suggest that the final stage and the 
death of the patient bring about the strongest display of grief. There are multiple losses 
for the caregiver, the loss of the previous relationship, social interaction an support, 
health status, resolution of pass issues, activities, previously established social roles, 
intimacy and control (Sanders & Adams, 2005). 
In another study, grief and depression was examined. A racially diverse sample 
of caregivers was drawn from an urban setting on the east coast of the United States. 
Results indicated not only that a significant proportion of caregivers experienced high 
levels of grief that may place them at risk of other difficulties, but also that grief was a 
significant predictor of increased depressive symptoms (Sanders & Adams, 2005). 
Another study investigated the predictors of caregiver burden and depression. 
The participants were 61 3 individuals with dementia, living in either the community or 
an institution, and their informal caregivers. Structural equation models representing 
four alternative pathways from care giving stressors (e.g., functional limitations, 
disturbing behaviors, patients' residence, and assistance given to caregiver) to caregiver 
burden and depression was compared. The data provided the best fit to a model whereby 
the effects on the caregivers well being are mediated by appraisals of burden. A higher 
frequency of disturbing behavior, caring for a community-dwelling patient, and low 
informal support were related to higher burden, which in turn led to more depressive 
symptomatology. Caregivers of patients exhibiting more disturbing behaviors and 
functional limitation received les help from family and friends, whereas those whose care 
recipients resided in an institution received more informal support (Clyburn, et al., 2000). 
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Sleath, et al., examined the relationship between race and psychotropic drug use 
(antidepressants, anti-anxiety, sedativehypnotics agents) in informal caregivers with 
symptoms of depression who provided care for elderly relatives with dementia. Whether 
racial differences in medication use relate to racial differences on predisposing, enabling, 
and need factors associated with use of these agents was also examined. There were 
2,932 African American and white caregivers of elderly male veterans diagnose with 
probable Alzheimer's disease or vascular dementia. Depressive symptoms were 
measured using a modified version of the Center for Epidemiological Studies 
Depressive Scale. Antidepressant, anti-anxiety, and sedativehypnotic agents were 
indexed using the Veterans Affairs' medication classification system. Of caregivers 
with depressive symptoms, 19% used anti-depressants, 23% anti-anxiety agents, and 
2% sedative hypnotics. African American caregivers with depressive symptoms were 
significantly less likely than whites with depressive symptoms to use antidepressants' 
and anti-anxiety medications. This study conclude that 8 1 % of caregivers had depressive 
symptoms and were not taking medication and that African American caregivers were 
less likely than whites to take antidepressants (Sleath, et al., 2005). 
Theoretical Framework 
The theoretical framework for this study was based on Systems Theory; a means 
by which some resolutions to the myriad of problems facing our society and the family 
may be beneficial. Systems Theory is an approach to human behavior. There are two 
substantive assumptions in defining Systems Theory: 1) The state or condition of a 
system, at any one point in time is a function of the interaction between it and the 
environment in which it operates; and 2) Change and conflict are always evident in a 
system (Longres, 1990). 
Two basic components of Systems Theory are elements and processes. Elements 
are measurable things that can be linked together. They are called objects, event, 
patterns, or structures. Processes change elements fiom one form to another. They are 
also called activities, relations, or functions. The family system and the organizations 
needed to serve the myriad of problems facing the Alzheimer client, caregiver and 
society are part of complex social systems meeting the needs and the events that take 
place in the progression of Alzheimer disease (Pavard & Dugdale, 2004). 
When utilizing Systems Theory for this dissertation the family is a smaller system 
with the involvement of multiple other larger systems of service. The communications 
between all systems must be open for services to meet the needs of the Alzheimer's client 
and caregiver. Systems are most productive when conflict arises and alternatives are 
established. When the diagnosis of Alzheimer's disease is established communication 
between all systems of services are needed. If systems are not in place to meet the needs 
of the client and caregiver then communication is developed between systems until a 
resolution can take place. The family as well as the larger systems must address the 
needs of the Alzheimer's epidemic among African American. These needs are met by 
larger systems such as Federal and sate fbnding for respite care, prescriptions, nursing 
homes, in home health care and assisted living (Gurrnan & Kniskern, 1979). 
The impact of Alzheimer disease on the family and society are astronomical. 
African Americans are being diagnosed disproportionately higher than any other 
ethnicity. Integration of available resources and available services must be tapped into. 
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Systems theory will serve as an intervention, enabling social workers to advocate on the 
grounds of empirical research in the area of social dynamics; as opposed to multiple 
studies whose focus is on the physiological aspects (Bruton, 2007). 
A secondary theoretical approach was incorporated into this paper. Behavior 
Cognitive Theory (BCT) is based on the concept that there is a reciprocal interaction 
between what we think, how we feel, and how we behave. This theory serves as an 
intervention for the caregiver. In BCT the problems are specified (i.e. aging, dementia, 
inability of the client to care for self, housing medications, access to health care, lack of 
participation in research etc). T he challenge at hand is identified as the focus of change, 
which may be collectively or one situation at a time. The behaviors or attitudes that may 
be changed, altered or suppressed are identified by the caregiver the Alzheimer's client 
and society. The system that is most likely to assist with the solutions of the problem is 
identified and ways are established with the help of social organizations to meet those 
needs (Cooper & Leer, 2005). 
The caregiver is then requested to obtain knowledge regarding available resources 
to assist in the care, both psychologically, emotionally and financially of the client. The 
caregiver may also began to set goals as specified in CBT secondary to the progressive 
nature of the disease and the need for hospice, respite care and possibly the need for 
placement issues associated with the final stage. The client may not be able to remain in 
the home and the caregiver may be requested to do homework to practice future skills 
that may be needed in order to identify future services needed as the disease process 
continues (Corcoran, 2006). 
CHAPTER I11 
METHODOLOGY 
Chapter I11 presents the methods and procedures that were used in conducting the 
study. The following are described: research design; description of the site; sample and 
population; instrumentation; treatment of data; and limitations of the study. 
Research Design 
A descriptive and explanatory research design was employed in this study. The 
study was designed to ascertain data in order to describe and explain the higher diagnosis 
of Alzheimer's disease in the Afi-ican American population. 
The descriptive and explanatory research design allowed for the descriptive 
analysis of the demographic characteristics of the respondents. Also, this research design 
facilitated the explanation of the statistical relationship between diagnosis of Alzheimer's 
disease among Afi-ican Americans and their socio-economic status, participation in 
research, caregiver knowledge and support systems, access to health care and medication 
and caregiver stressors for family members with the diagnosis of Alzheimer's. 
Description of the Site 
The research study was conducted in Atlanta Georgia. Atlanta is the largest urban 
metropolitan city in the state of Georgia. The surveys were administered at Sadie G. 
Mayes Nursing Home, Staff Builders Home Health Care and Ashton Hall Assisted 
Living Facilities. The assisted living facilities were selected due to the selection of both 
male and female clients and involvement in patients care. Caregivers that were not 
present during the session were interviewed by phone. 
Sample Population 
The target population for the research was composed of primary caregivers for 
patients diagnosed with Alzheimer's disease. One hundred (1 00) respondents were 
selected utilizing non-probability convenience sampling from among the participants at 
the selected sites for the study. 
Instrumentation 
The research study employed a survey questionnaire entitled Alzheimer's 
Awareness. The survey questionnaire consisted of 6 sections with a total of 30 questions. 
The questions were answered by the caregiver or family member of the client. The first 
section solicited demographic information about the characteristics of the patient or 
relative of the respondent. 
Section I consisted of three questions numbers 1-3 as independent variables of the 
study. The questions in Section I were related to gender, age and ethnicity. 
Sections I1 of the survey consisted of three questions numbers 4-6, and were 
independent variables to determine socio-economic status. The questions in Section I1 
were income, occupation and educational level. Section I and I1 provided information for 
the presentation of a demographic profile on the respondents of the research study as well 
as serving as independent variables. 
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Section I11 of the survey consisted of four (4) questions numbered 7-10. The four 
(4) questions were related to research participation in Alzheimer's disease studies. Items 
were responded to on a four point continuum Likert Scale. The scale was as follows: 
1 = Disagree; 2 = Somewhat Disagree; 3 = Agree; 4 =Strongly Agree. 
Section IV consisted of eight (8) questions numbers 1 1-1 8 related to caregiver 
knowledge using a "yes" "no" response. Participants' answered questions related to their 
knowledge of Alzheimer's disease and these responses served as independent variables 
Section V consisted of five (5) questions numbers 20-24 and were related to 
access to health care and medications. A "yes" "no" response was measured and 
questions served as independent variables. Two questions are open ended with suggested 
responses. 
Section VI (6) the six questions numbers 25-30 using a four point Likert scale to 
measure stressors related to care giving of an Alzheimer's disease patient. The scale was 
as follows: 1 = Disagree; 2 = Somewhat Agree 3 = Agree; 4 = Strongly Agree. 
Treatment of Data 
Statistical treatment of the data employed descriptive statistics, which include 
measures of central tendency, frequency distribution, and cross tabulation. The test 
statistics for the study were phi and chi square. 
Frequency distribution was used to analyze each of the variables of the study in 
order to summarize the basic measurements. A frequency distribution of independent 
variables was used to develop a demographic profile and to gain insights about the 
respondents of the study. 
delivery, when attempting to understand variations in access to services. In order to 
improve access to services, it will be necessary to move beyond addressing individual 
factors relating to access, and to consider the impact of the framework for service 
delivery and the relationships that influence contact with services (Pratt, Claire & 
Kirchner, 2006). 
A cohort study of African American patients and their caregivers presenting at a 
suburban memory assessment clinic and were diagnosed with probable Alzheimer's 
disease were interviewed. Data was collected about the delay from noticing first 
Alzheimer's disease signs until recognition that a problem existed and delay from 
problem recognition until first physician consult. Median delays in caregivers' 
recognizing a problem and in consulting a physician were as long as seven years. Lack 
of physician contact is likely to be widespread in families caring for African American's 
with Alzheimer's disease. Intensive efforts are needed to connect African American 
families with physicians and to achieve more timely diagnosis of Alzheimer's disease to 
enable families to understand the illness, plan for patient safety, make long term care 
plans and gain access to health care services (Clark, et al., 2005). 
Although there is no cure for Alzheimer's disease there are a number of drugs that 
are available globally that can help slow cognitive deterioration. The aim of Alzheimer's 
disease medications is to improve cognitive ability to think, perceive, judge and 
recognize (Alzheimer's Fact Sheet, 2007). 
President Clinton underscored the need for a Medicare Prescription Drug Benefit 
plan in July 2000 in light of research prevention of Alzheimer's disease. He stressed 
". ..there must be a commitment to pursuing research possibilities equaled by our efforts 
to provide an affordable, meaningful, prescription drug benefit option for all Medicare 
beneficiaries in order to obtain present medications for Alzheimer's disease " 
(Whitehouse Backgrounder, 2000). 
Most low-income elderly and disabled persons lack coverage for important 
medications, resulting in unavoidable deterioration of health among those with chronic 
illnesses and use of expensive institutional services. Rapidly escalating drug cost, more 
restrictive drug coverage policies, and a dramatic increase in the population of elderly 
persons will exacerbate these problems. With the current budget surplus, as well as 
bipartisan concern about health care needs and public concern about drug costs and 
coverage, the Harvard Medical School in Boston, MA feels that it is time to act 
responsibly and aggressively. The recommendation is that a national replication of the 
best features of a state pharmacy assistance program in a federal-sate insurance program 
for low-income Medicare enrollees, either alone or in combination, with expanded 
Medicare coverage. Such a program would reduce the current inequitable situation in 
which the most vulnerable patients have the least access to medications, with serious 
medical and economic consequences (Soumerai & Ross-Degnan, 1999). 
There are five prescription drugs currently approved by the U.S. Food and Drug 
Administration to treat people with Alzheimer's disease. Treating the symptoms 
Alzheimer's disease can provide patients with comfort, dignity and independence for a 
longer period of time and can encourage and assist their caregiver as well. Mild to 
Moderate Alzheimer's disease is treated with Reminyl, Exelon, Aricept, and Cognex. 
To treat Moderate to Severe Alzheimer's disease, Namenda is used and may help the 
patient maintain the ability to go to the bathroom independently for several more months, 
a benefit for both patient and caregiver (Alzheimer's Disease Medication Fact Sheet, 
2007). 
The cost for Alzheimer's disease medication averages about $5.00 per day. 
Listed below are the average costs to the pharmacy. Aricept $142.00 per month, Exelon 
$134.00 per month and Reminyl $130.00 per month is the estimated average cost to the 
pharmacy prior to prescription filling fee. Namenda and Cognex bear a heavier monthly 
cost due to the new emergence of these drugs, which may be found in the neighborhood 
of $175-$250 per month prior to prescription filling fee, with no generics currently 
available for any of the medications listed above (Delagarza, 2003). 
A cross sectional survey, of a national sample of 4050 adults aged 50 years or 
older who use prescription medications for at least five chronic health conditions were 
surveyed. The primary outcome measure was patient report of being asked by a doctor or 
nurse in the prior 12 months whether the patient could afford the prescribed medications. 
The measures of prescription cost burden were cost-related underuse of medications, 
cutting back on other necessities to pay for medications, and worries about medication 
costs. Adjustment was made for patient income, education, racelethnicity, age, sex, and 
health status, number of prescribed medications, pharmacy benefits, and frequency of out 
patient visits, having a regular health care provider and sampling weights. In the 
weighed analysis, 16% of the respondents reported that they had been asked about 
potential problems paying for prescribed medications. Only 24% of the 1499 
respondents who reported one or more burdens from out-of-pocket medication costs 
reported being asked this question. After an adjustment was made for potential 
cofounders, patients who had cut back on medications use or other necessities to cover 
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payments were no more likely than other patients to be asked about the ability to pay for 
prescription medications. Concerns about medication, being a raciallethnic minority, 
taking seven or more prescription medications, and having no prescription coverage were 
independently associated with a greater likelihood of being asked about possible 
problems with prescriptions (Heisler, et al., 2003). 
It is widely recognized that the ability to pay effects physicians care, 
hospitalizations and medications. It has been hypothesized that persons with higher 
incomes and better health insurance coverage are more likely to medicate common health 
problems than those with lower incomes and less comprehensive coverage. A landmark 
study in 1998 surveyed 4,066 elderly Pennsylvania Medicare beneficiaries. These 
beneficiaries were asked to complete a mail survey on health insurance, income and 
medicine use for 23 common health problems. The relationship between ability to pay 
and medication decisions was analyzed using Poisson logistic regression models with 
covariates for socio-demographic characteristics and health status. The results showed a 
strong and consistent relationship in the hypothesized direction. 
Other things being equal, elderly persons with Medicare supplementation were 
between 6% and 17% more likely to use prescription medicine to treat their health 
problems than were persons with Medicare coverage alone. The elderly with annual 
incomes greater than $1 8,000 were 18% more likely to treat problems with prescription 
drugs than were persons with an annual income less than $6,000. This research 
concludes that economic factors appeared to play an important role in medication 
decisions by the elderly. The magnitude of the impact was sufficiently high so that it 
could have major negative consequences on the health of elderly persons who are poor 
and lack drug coverage (Stuart & Grana, 1998). Though President Clinton understood 
the need for Prescription Drug Benefit plan, healthcare utilization and access must 
become more culturally sensitive in order to increase utilization of services by African 
Americans. 
Research by George Rust (2004) utilized secondary data of 3,462 records of 
African American respondents to the 1999 Medical Expenditure Survey Household file. 
They concluded that there was a significant variation in the number of office visits, 
outpatient clinic visits, hospital discharges, and the number of days hospitalized and 
prescriptions filled among this population. There were three modifiable factors, poverty, 
insurance, and lack of a primary care physician as having a striking effect for African 
American patients. Barriers to utilization of services were noted as availability, 
accessibility and acceptability. 
Availability of services was linked to sometimes not being able to obtain a 
primary care physician where ethnic elders lived. Even more difficult was specialty care 
physicians in the areas where many African Americans reside. Accessibility was 
determined by the African American as available care but the inability to use or access 
services for a number of reasons measured were: lack of knowledge, distrust of the 
system, fear of punitive action, inability to deal with bureaucracy, assumptions by 
providers of lack of motivation or trust and transportation difficulties. Acceptability of 
the patient was linked as another barrier to access and utilization of services and was 
based on patients' satisfaction with having their expectations met. Acceptability was an 
aspect of access and utilization of services most affected by culture and the interaction 
between patient and provider performance. Trust needed to be developed between the 
provider and patient in order to gain access to services. In order to gain access and 
utilize services, indigenous networks for education and outreach must be formulated. 
Utilization of churches, temples, lay leaders and non-professional advocates can be 
utilized to increase access to medication and services for African Americans with 
Alzheimer's disease. 
Caregiver Stressors 
Some five million Americans care for loved ones with Alzheimer's disease at 
home, in nursing homes or assisted living facilities. Many caregivers feel isolated from 
family, fiends and their communities. Stress levels of caregivers rise as Alzheimer's 
disease symptoms grow and become more severe. Social support is needed to help bear 
not only the financial burden, but the psychological and social aspects of those diagnosed 
with Alzheimer's disease. Improving social support and reducing family conflict to help 
the caregiver withstand the hardships of care giving requires a multitude of social support 
systems. To help society and other family members understand the primary caregiver's 
needs and how to best become helpfbl may postpone the institutionalization of patients 
diagnosed with Alzheimer's disease (Fisher Center, 2006). 
Caregivers who lack sufficient or appropriate social support are often put under 
heightened stress. Family conflicts, isolation, loneliness further exacerbate the stress of 
the caregiver. While social support may not affect primary stress caused by Alzheimer's 
disease, it can change the caregivers' response to the illness. Feeling supported by 
social/community services and family can improve the psychological response to stress 
and boost the caregivers sense of well being. Caregivers can benefit from formal support 
by community services such as in home respite or day care programs for the patient, and 
support groups in conjunction with the informal support of family and friends 
(Alzheimer's Caregivers Fact Sheet, 2007). 
More than 80% of Alzheimer's caregivers report that they frequently experience 
high levels of stress, and nearly half say they suffer from depression. The National 
Family Caregiver Alliance terms caregiver depression as "...one of today's all-to-silent 
health crises". The alliance estimates that care giving spouses the ages of 66 to 96 who 
are experiencing mental or emotional strain have a 63% higher risk of dying than people 
the same age who are not caregivers (Abe1,2003). 
Caregivers often experience feelings of guilt, believing they are not doing enough 
to help. Spouses and adult children feel grief and loss except for being sudden, it spreads 
over years. Alzheimer's is a progressively worsening disease, but the rate of progression 
from mild to advanced stages can vary from three to 20 years. As the disease progresses, 
the loss of brain h c t i o n  itself will cause death unless the patient has one or more other 
serious illnesses (Health Link Fact Sheet, 2003). 
Financial strain from the disease process brings about problems that can also add 
to stress and depression. Caregivers will often give up paying jobs for the unpaid job of 
caring for the family member with Alzheimer's disease. Additional responsibilities are 
thrust upon them such as over seeing medication rkgime, taking on power of attorney 
along with living wills and advance directives that specify whether terminal patients 
should undergo extreme measures to keep them alive. In the book "The 36 Hour Day, 
Mace and Rabins made the first reference to caregiver stressors: 
As the patient's illness progresses and the person changes, you may 
experience the loss of a companion and a relationship that was important 
to you. You may grieve the way she use to be. We usually think of grief 
as an emotional experience that follows death. However, grief is a natural 
emotional response to loss and so it is a normal experience for people who 
love a person with a chronic illness (p. 209). 
Caregiver's of individuals with Alzheimer's disease are at an increased risk of 
mental and physical problems as a result of the strain that accompanies this role. Despite 
clear indications that caregiver grief and feelings of loss are normal, researchers did not 
begin to address the idea until late 1980's and mid 1990's. Two of the earliest 
researchers on this topic were Wasow and Coons. They indicated that the grief of 
caregivers of individuals with Alzheimer's disease often remained undetected by society. 
Not recognized as normative behavior, grief and loss were combined with feelings of 
stigma which was often associated with the disease (Wasow & Coons, 1987). 
In 1999, Boss coined the term "ambiguous loss" to define grief that has no clear 
starting point and no clear ending point. This type of grief experienced by Alzheimer's 
disease caregivers is ambiguous because the care recipient is still physically present, but 
cognitively not the same person. Boss argued that the depression commonly noted in 
caregivers of individuals with Alzheimer's disease probably has more to do with the 
ambiguity of their loss than their heavy work load. The feeling of being out of control 
commonly associated with ambiguous losses can lead to increase family conflict; 
problematic communication patterns an obsession with the day to day activities of caring 
for the patient (Boss, 1 999). 
There is also grief at different stages of the disease. The profound feelings of 
grief expressed following the diagnosis of Alzheimer's disease. Grief becomes stronger 
when the patient no longer recognizes the caregiver which often occurs in the middle 
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stages of the disease progression. Other researchers suggest that the final stage and the 
death of the patient bring about the strongest display of grief. There are multiple losses 
for the caregiver, the loss of the previous relationship, social interaction an support, 
health status, resolution of pass issues, activities, previously established social roles, 
intimacy and control (Sanders & Adams, 2005). 
In another study, grief and depression was examined. A racially diverse sample 
of caregivers was drawn from an urban setting on the east coast of the United States. 
Results indicated not only that a significant proportion of caregivers experienced high 
levels of grief that may place them at risk of other difficulties, but also that grief was a 
significant predictor of increased depressive symptoms (Sanders & Adams, 2005). 
Another study investigated the predictors of caregiver burden and depression. 
The participants were 61 3 individuals with dementia, living in either the community or 
an institution, and their informal caregivers. Structural equation models representing 
four alternative pathways from care giving stressors (e.g., functional limitations, 
disturbing behaviors, patients' residence, and assistance given to caregiver) to caregiver 
burden and depression was compared. The data provided the best fit to a model whereby 
the effects on the caregivers well being are mediated by appraisals of burden. A higher 
frequency of disturbing behavior, caring for a community-dwelling patient, and low 
informal support were related to higher burden, which in turn led to more depressive 
symptomatology. Caregivers of patients exhibiting more disturbing behaviors and 
functional limitation received les help from family and friends, whereas those whose care 
recipients resided in an institution received more informal support (Clyburn, et al., 2000). 
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Sleath, et al., examined the relationship between race and psychotropic drug use 
(antidepressants, anti-anxiety, sedativehypnotics agents) in informal caregivers with 
symptoms of depression who provided care for elderly relatives with dementia. Whether 
racial differences in medication use relate to racial differences on predisposing, enabling, 
and need factors associated with use of these agents was also examined. There were 
2,932 African American and white caregivers of elderly male veterans diagnose with 
probable Alzheimer's disease or vascular dementia. Depressive symptoms were 
measured using a modified version of the Center for Epidemiological Studies 
Depressive Scale. Antidepressant, anti-anxiety, and sedativehypnotic agents were 
indexed using the Veterans Affairs' medication classification system. Of caregivers 
with depressive symptoms, 19% used anti-depressants, 23% anti-anxiety agents, and 
2% sedative hypnotics. African American caregivers with depressive symptoms were 
significantly less likely than whites with depressive symptoms to use antidepressants' 
and anti-anxiety medications. This study conclude that 8 1 % of caregivers had depressive 
symptoms and were not taking medication and that African American caregivers were 
less likely than whites to take antidepressants (Sleath, et al., 2005). 
Theoretical Framework 
The theoretical framework for this study was based on Systems Theory; a means 
by which some resolutions to the myriad of problems facing our society and the family 
may be beneficial. Systems Theory is an approach to human behavior. There are two 
substantive assumptions in defining Systems Theory: 1) The state or condition of a 
system, at any one point in time is a function of the interaction between it and the 
environment in which it operates; and 2) Change and conflict are always evident in a 
system (Longres, 1990). 
Two basic components of Systems Theory are elements and processes. Elements 
are measurable things that can be linked together. They are called objects, event, 
patterns, or structures. Processes change elements fiom one form to another. They are 
also called activities, relations, or functions. The family system and the organizations 
needed to serve the myriad of problems facing the Alzheimer client, caregiver and 
society are part of complex social systems meeting the needs and the events that take 
place in the progression of Alzheimer disease (Pavard & Dugdale, 2004). 
When utilizing Systems Theory for this dissertation the family is a smaller system 
with the involvement of multiple other larger systems of service. The communications 
between all systems must be open for services to meet the needs of the Alzheimer's client 
and caregiver. Systems are most productive when conflict arises and alternatives are 
established. When the diagnosis of Alzheimer's disease is established communication 
between all systems of services are needed. If systems are not in place to meet the needs 
of the client and caregiver then communication is developed between systems until a 
resolution can take place. The family as well as the larger systems must address the 
needs of the Alzheimer's epidemic among African American. These needs are met by 
larger systems such as Federal and sate fbnding for respite care, prescriptions, nursing 
homes, in home health care and assisted living (Gurrnan & Kniskern, 1979). 
The impact of Alzheimer disease on the family and society are astronomical. 
African Americans are being diagnosed disproportionately higher than any other 
ethnicity. Integration of available resources and available services must be tapped into. 
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Systems theory will serve as an intervention, enabling social workers to advocate on the 
grounds of empirical research in the area of social dynamics; as opposed to multiple 
studies whose focus is on the physiological aspects (Bruton, 2007). 
A secondary theoretical approach was incorporated into this paper. Behavior 
Cognitive Theory (BCT) is based on the concept that there is a reciprocal interaction 
between what we think, how we feel, and how we behave. This theory serves as an 
intervention for the caregiver. In BCT the problems are specified (i.e. aging, dementia, 
inability of the client to care for self, housing medications, access to health care, lack of 
participation in research etc). T he challenge at hand is identified as the focus of change, 
which may be collectively or one situation at a time. The behaviors or attitudes that may 
be changed, altered or suppressed are identified by the caregiver the Alzheimer's client 
and society. The system that is most likely to assist with the solutions of the problem is 
identified and ways are established with the help of social organizations to meet those 
needs (Cooper & Leer, 2005). 
The caregiver is then requested to obtain knowledge regarding available resources 
to assist in the care, both psychologically, emotionally and financially of the client. The 
caregiver may also began to set goals as specified in CBT secondary to the progressive 
nature of the disease and the need for hospice, respite care and possibly the need for 
placement issues associated with the final stage. The client may not be able to remain in 
the home and the caregiver may be requested to do homework to practice future skills 
that may be needed in order to identify future services needed as the disease process 
continues (Corcoran, 2006). 
CHAPTER I11 
METHODOLOGY 
Chapter I11 presents the methods and procedures that were used in conducting the 
study. The following are described: research design; description of the site; sample and 
population; instrumentation; treatment of data; and limitations of the study. 
Research Design 
A descriptive and explanatory research design was employed in this study. The 
study was designed to ascertain data in order to describe and explain the higher diagnosis 
of Alzheimer's disease in the Afi-ican American population. 
The descriptive and explanatory research design allowed for the descriptive 
analysis of the demographic characteristics of the respondents. Also, this research design 
facilitated the explanation of the statistical relationship between diagnosis of Alzheimer's 
disease among Afi-ican Americans and their socio-economic status, participation in 
research, caregiver knowledge and support systems, access to health care and medication 
and caregiver stressors for family members with the diagnosis of Alzheimer's. 
Description of the Site 
The research study was conducted in Atlanta Georgia. Atlanta is the largest urban 
metropolitan city in the state of Georgia. The surveys were administered at Sadie G. 
Mayes Nursing Home, Staff Builders Home Health Care and Ashton Hall Assisted 
Living Facilities. The assisted living facilities were selected due to the selection of both 
male and female clients and involvement in patients care. Caregivers that were not 
present during the session were interviewed by phone. 
Sample Population 
The target population for the research was composed of primary caregivers for 
patients diagnosed with Alzheimer's disease. One hundred (1 00) respondents were 
selected utilizing non-probability convenience sampling from among the participants at 
the selected sites for the study. 
Instrumentation 
The research study employed a survey questionnaire entitled Alzheimer's 
Awareness. The survey questionnaire consisted of 6 sections with a total of 30 questions. 
The questions were answered by the caregiver or family member of the client. The first 
section solicited demographic information about the characteristics of the patient or 
relative of the respondent. 
Section I consisted of three questions numbers 1-3 as independent variables of the 
study. The questions in Section I were related to gender, age and ethnicity. 
Sections I1 of the survey consisted of three questions numbers 4-6, and were 
independent variables to determine socio-economic status. The questions in Section I1 
were income, occupation and educational level. Section I and I1 provided information for 
the presentation of a demographic profile on the respondents of the research study as well 
as serving as independent variables. 
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Section I11 of the survey consisted of four (4) questions numbered 7-10. The four 
(4) questions were related to research participation in Alzheimer's disease studies. Items 
were responded to on a four point continuum Likert Scale. The scale was as follows: 
1 = Disagree; 2 = Somewhat Disagree; 3 = Agree; 4 =Strongly Agree. 
Section IV consisted of eight (8) questions numbers 1 1-1 8 related to caregiver 
knowledge using a "yes" "no" response. Participants' answered questions related to their 
knowledge of Alzheimer's disease and these responses served as independent variables 
Section V consisted of five (5) questions numbers 20-24 and were related to 
access to health care and medications. A "yes" "no" response was measured and 
questions served as independent variables. Two questions are open ended with suggested 
responses. 
Section VI (6) the six questions numbers 25-30 using a four point Likert scale to 
measure stressors related to care giving of an Alzheimer's disease patient. The scale was 
as follows: 1 = Disagree; 2 = Somewhat Agree 3 = Agree; 4 = Strongly Agree. 
Treatment of Data 
Statistical treatment of the data employed descriptive statistics, which include 
measures of central tendency, frequency distribution, and cross tabulation. The test 
statistics for the study were phi and chi square. 
Frequency distribution was used to analyze each of the variables of the study in 
order to summarize the basic measurements. A frequency distribution of independent 
variables was used to develop a demographic profile and to gain insights about the 
respondents of the study. 
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Cross tabulation were utilized to demonstrate the statistical relationship between 
independent variables and the dependent variable. Cross tabulations were conducted 
between high and low socio-economic status and the diagnosis of Alzheimer's disease, 
the lack of distrust and participation in research, institutionalization and knowledge of 
Alzheimer's disease process, association between access to medication and diagnosis 
and the association of diagnosis of depression and the care of Alzheimer's relative in the 
African American population. 
Two test statistics will be employed. The first test was Phi (0) which is a 
symmetric measure of association that is used to demonstrate the strength of relationship 
between two or more variables (Bromstead & Knoke, 1995). The following are the 
valuables associated with phi (0): 
.OO to .24 "no relationship" 
.25 to .49 "weak relationship" 
.50 to .74 "moderate relationship" 
.75 to 1 .OO "strong relationship" 
The second test statistics employed in he research study was chi square. Chi 
Square was used to test whether there was statistical significance at the .05 level of 
probability among variables in the study. 
Limitations of the Study 
There were two basic limitations to the study. The first limitation was the 
inability of the caregiver to have a broad knowledge of the patient's socio-economic 
status and access to health care history prior to the onset of memory loss. The second 
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limitation was the lack of sites made available for this study secondary to confidentiality 
of many facilities to allow an outside practitioner to gain access to caregivers of patients 
with Alzheimer's disease due to confidentiality (i.e., HIPAA Guidelines). 
CHAPTER IV 
PRESENTATION OF FINDINGS 
The purpose of this chapter was to present the findings of the study in order to 
describe and explain the social barriers leading to the disproportionately higher incidence 
of Alzheimer's' disease in the Afi-ican American population. This chapter presents the 
findings of the study. The findings are organized into two sections: demographic data 
and research questions and hypotheses. 
Demographic Data 
This section provides a profile of the study respondents. Descriptive statistics 
were used to analyze the following: gender, age group, and ethnicity. 
A target population for the research was composed of caregivers of patients with 
Alzheimer's disease living or deceased. Ninety caregivers were selected utilizing 
convenience sampling from among participants of the selected sites. 
As indicated in Table 1, the typical respondent of the study was African 
American, a female and seventy-one years or older. 
Table 1 
Demographic Profile of Study Respondents 














Research Questions and Hypotheses 
There were five research questions and five null hypotheses in the study. This 
section provides as analysis of the research questions and testing of the null hypotheses. 
Research Question1 : Is there a relationship between socio-economic status and the 
diagnosis of Alzheimer's' disease? 
Hypothesis 1 : There is no statistically significant relationship between low 
socio-economic status in the African American population and the 
diagnosis of Alzheimer's disease. 
Socio-economic Status of Alzheimer's Patients 
Numerous studies have documented the importance of socio-economic status 
(SES) to a variety of health outcomes. The National Committee on Vital Statistics and 
other federally-sponsored health conferences has recommended regular collection of SES 
data and for the use of SES variables in studies of differential health outcomes (Daly, et 
al., 2000). 
In the study socio-economic status was defined as the patients' occupation, 
education and income level. Table 2 is a frequency distribution of nine (9) occupations 
reported by the caregiver of the patients last employment status prior to the Alzheimer's 
patients retirement. 
As shown in Table 2, the greatest percentile of Alzheimer's patients were in the 
lower occupational category of Helper-Laborer, 33.3% with an executive percentage of 
6.4%. 
Table 2 
Occupation of Alzheimer's Respondents 












Another measure of socio-economic status was the educational level of the 
Alzheimer's survey respondent of their relative diagnosed with Alzheimer's disease. 
Studies show that fewer years of formal schooling, lower income and lower occupational 
status each predicted risk of incident of Alzheimer's. The risk of Alzheimer's disease 
decreased approximately 17% for each year of education (Evans 2007). Table 3 is a 
fi-equency distribution of the level of education of each respondent. 
Table 3 
Educational Level of Respondents 
Variable Frequency Percent 
Education 
Elementary 







As displayed in Table 3 the greatest educational level of respondents was between 
"Some High School" (35.5%) and "College Graduates" (1 8.9%) with Elementary in third 
place at fourteen percent (14.4%). 
Income has been more widely used as a measure of SES in the United States than 
anywhere else. Studies in the U.S. and the United Kingdom found that indicators of 
wealth, independent of the more traditional indicators is more valuable as a SES variable. 
The income reflects the value of human wealth or capital (Daly, et al, 2000). 
Table 4 
The Income of Respondents Diagnosed with Alzheimer's Disease 
Income Yes No Total 
Under 30,000 30 34.9% 30 34.9% 60 69.8% 
30'00 1-40,000 20 23.3% 6 7.0% 26 30.2% 
As indicated in Table 4 the income of respondents taking medications and have a 
diagnosis of Alzheimer's disease with income under 30,000 was 69.8% and those with 
incomes over 30,001 and taking medications was 30.2%. 
The statistical measurement phi (0) was employed to test for strength of 
association between income and Alzheimer's diagnosis. As indicated there was a weak 
relationship (0= .25 1) between income and diagnosis of Alzheimer's disease. When the 
chi-square statistical test for significance was applied, the null hypothesis was not 
rejected (p=.0200 indicating that there was a statically significant relationship between 
the two variables at the .05 level of probability. 
Research Question 2: Is there a relationship between African American participation in 
research and lack of trust in the medical/research field? 
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Hypothesis 2: There is no evidence of a relationship between African American 
participants in research and lack of trust in the medicallresearch field. 
Participation in Research 
Trust is an important element of communication and many ethnic elders lack trust 
in health care professionals as well as the American health system. As the older 
population becomes more ethnically diverse, health professionals will need to become 
more knowledgeable about the cultural backgrounds of their clients to obtain subjects to 
participate in Alzheimer's research (Washington, 2006). 
Table 5 is a cross tabulation of participation in research and the lack of trust in the 
medicallresearch field of those diagnosed with Alzheimer's disease. As indicated in 
Table 5 a large majority of respondents, 65.9%' agree that research risk is not shared 
equally by all while 34.1% agree that risk for research is shared equally. 
Table 5 
Risk for Research not Shared Equally 
Income Yes No Total 




As indicated in Table 5, the statistical measurement phi (0) was employed to test 
for the strength of association between risk shared in medicallresearch fields by all 
ethnicities. As indicated there was a weak relationship (0 =.03 1) between the two 
variables. When the chi-square statistical test for significance was applied, the null 
hypothesis was rejected (p=.775) indicating that there was a statistically significant 
relationship between the two variables at the .05 level of probability. 
Research Question 3: Is there a relationship between institutionalization of the client 
with Alzheimer's disease and caregiver knowledge and support? 
Hypothesis 3: There is no relationship between institutionalization of the client with 
Alzheimer's disease and the caregiver knowledge and support. 
With the current aging of U.S. population, the number of those with Alzheimer's 
disease is rapidly increasing, along with the financial impact of the disease on society. 
Research is expanding both to prevent or delay the disease and to assist the caregiver in 
maintaining the patient in the home. More than 75% of those diagnosed with 
Alzheimer's disease are cared for in the home (Stanton, 2001). 
Table 6 is a crosstabulation of the institutionalization by Alzheimer's patients. It 
shows the association between institutionalization of Alzheimer's patients and support of 
other family members in the care of the patient and maintain the patient in the home. 
Table 6 
Residence of Alzheimer's Patients 
Residence Yes No Total 
Yes 
No 
As indicated in Table 6, 13.6% of patients diagnosed with Alzheimer's disease 
resided in and assisted living facility or nursing home and 56.8% remained in the home 
with support from family members. 
As shown in Table 6, the statistical measurement phi (0) was employed to test for 
strength of association between residence and support of family members in the care of 
the Alzheimer's patient. As indicated there was no relationship (0= .084) between the 
two variables. When the chi-square statistical test for significance was applied, the null 
hypothesis was not rejected (p=.43 1) indicating that there was a statistically significant 
relationship between the two variables at the .05 level of probability. 
In Table 7 is a crosstabulation of knowledge by available community resources. 
It shows the association of the Alzheimer's caregivers knowledge and the patients place 
of residence (i.e., institutionalization versus in-home care). 
Table 7 
Community Resources 
Community Resources Yes No Total 
Yes 
No 
As indicated in Table 7,41.4 % of caregivers are aware of community resources 
of those patients who remain in the home and 58.6% are not aware of available 
community resources of those patients who remain in the home. 
As shown in Table 7, the statistical measurement phi (0) was employed to test for 
the strength of association between ability to remain in the home and institutionalization 
of the patient by the caregiver. As indicated there was no relationship ( 0=.064) between 
the two variables. When the chi-square statistical test for significance was applied, the 
null hypothesis was not rejected (p= .549)) indicating that there was a statistical 
significant relationship between the two variables at the .05 level of probability. 
Research Question 4: Is there a relationship between diagnosis of Alzheimer's disease in 
the African American population and the access to health care and 
medication? 
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Hypothesis 4: There is no statistically significant relationship between the diagnosis of 
Alzheimer's disease in the African American population and the access to 
health care and medication. 
Early identification of Alzheimer's disease provides opportunities to initiate 
treatment that may slow a patients disease progression until the family member can 
connect and access health care providers and supportive services. The factors that may 
improve access to services for people with dementia are measured. 
Table 8 is a crosstabulation of access to healthcare by medication. It shows the 
association of the diagnosis of Alzheimer's disease by compliance of the patient in 
relationship to access to mediation and services. 
As indicated in Table 8, of the caregiver respondents' only 38.8 % were given 
handouts at the time of diagnosis. The majority (61.2%) indicated that they were not 
given any additional information after the diagnosis of Alzheimer's disease or assistance 
with medication or access to other health care services. 
As shown in Table 8, the statistical measurement phi (0) was employed to test for 
the strength of association between diagnosis and access to other healthcare services. As 
indicated, there was a weak relationship (0=.266) between the two variables. When the 
chi-square statistical test for significance was applied, the null hypothesis was rejected 
(p=.014) indicating that there was no statistically significant relationship between the two 
variables at the .05 level of probability. 
Table 8 
Access to Health Caremedication 
Diagnosis Yes No Total 
Handouts # % # % # % 
Yes 
No 
Research Question 5: Is there a significant relationship between caregiver stressors and 
caring for an Alzheimer's relative? 
Hypothesis 5: There is no statistically significant relationship between caregiver 
stressors and caring for Alzheimer's disease relative. 
Some five million Americans care for loved ones with Alzheimer's disease at 
home, in nursing homes or assisted living facilities. Stress levels of caregivers rise as 
Alzheimer's disease grows and become more severe. Improvement in social support and 
reducing family conflict to help the caregiver withstand the hardships of care giving 
requires a multitude of support (Fisher Center, 2006). 
Table 9 is a crosstabulation of caregiver stressors. It shows the association of 
caring for a relative with Alzheimer's disease and lack of personal time as evidenced by 
producing a strain on the caregiver. As indicated in Table 9,47.1% respondents disagree 
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with stress involved in caring for the relative with Alzheimer's disease and 52.9% agree 
with associated stress in the care of the relative with Alzheimer's disease. 
In table 9 the statistical measurement phi (0) was employed to test for the 
strength of association between caregiver stress by caring for the Alzheimer's patient. 
As indicated, there was no relationship ( 0=.219) between the two variables. When the 
chi-square statistical test for significance was applied, the null hypotheses was rejected 
(p=.043) indicating that there was no statistically significant relationship between the two 
variables at the .05 level of probability. 
Table 9 
Caregiver Strain 




CONCLUSIONS AND RECOMMENDATIONS 
The research study was designed to answer five questions concerning social 
aspects related to the higher incidence of Alzheimer's diagnosis in the African American 
population. Those aspects were socio-economic status, lack of trust and participation in 
research, knowledge and support in relationship to institutionalization, access to 
healthcarelmedication upon diagnosis and the relationship of stress among caregivers of 
Alzheimer's patients. 
The conclusions and recommendations of the research findings are presented in 
this chapter. Recommendations are proposed for future discussions for policy makers, 
social workers, practitioners, the medical field, administrators and schools of social work. 
Each research question is presented in order to summarize the significant findings of 
interest. 
Research Question 1 : Is there a relationship between socio-economic status and the 
diagnosis of Alzheimer's disease? 
In order to determine if there was a relationship to diagnosis of Alzheimer's 
disease by socio-economic status three variables were analyzed, occupation, education 
and income of the Alzheimer's patient. 
Of the 90 respondents surveyed for the nine (9) occupations given: executive, 
professional, technical, service organization, machinist, service occupation, 
helperllaborer, transportation, and clerical. The largest number of respondents (26) was 
helperllaborers ( 28.9%). The smallest percentage of respondents at 5.6% were 
executives and clerical workers (See Table 2). 
The educational level of the respondents was highest, 21.1% for "Some High 
School" and the lowest percentage (1.1%) was at the Doctoral Level" (See Table 2). 
The income level of the respondents was highest (69.8%) for incomes under 
$30,000 per year and 30.2% had incomes over $30.001 per year (See Table 4). 
The statistical measurement phi (0) was employed to test for strength of 
association between income an diagnosis of Alzheimer's disease. As indicated there was 
a weak relationship (0=.25 1) between the variables. When the chi-square statistical test 
for significance was applied, the null hypotheses was not rejected (p=.02) indicating that 
there was a statistically significant relationship between the two variables at the .05 level 
of probability (See Table 4). 
Research Question 2: Is there a relationship between African American participation in 
research and lack of trust in the medicallresearch field? 
Sixty-five point nine percent (65.9%) of the respondents agreed that research risk 
is not shared equally by all while 34.1% agreed research is shared equally (See Table 5). 
The statistical measurement phi (0) was employed to test for the strength of 
association between risk of research being shared equally by all ethnicities. As indicated, 
there was a weak relationship (0=.03 1) between the two variables. When the chi-square 
statistical test for significance was applied the null hypotheses was rejected (p=.775) 
indicating that there was a statistically significant relationship between the two variables 
at the .05 level of probability (See Table 5). 
Research Question 3: Is there a relationship between institutionalization of the client 
with Alzheimer's' disease and caregiver knowledge and support? 
Seventy point five percent (70.5%) of respondents reported that patients with 
Alzheimer's disease remained in the household with the support of family members as 
opposed to the 29.5% who reported that patients resided in nursing homes or assisted 
living facilities when family support was present. 
The statistical measurement phi (0) was employed to test the strength of 
association between support and institutionalization. As indicated, there was no 
relationship (0=.084) between the two variables. When the chi-square statistical test for 
significance was applied the null hypotheses was not rejected (p=.43 1) indicating that 
there was a statistically significant relationship between the two variables at the .05 level 
of probability (See Table 6). 
As indicated in Table 7,41.4% respondents had knowledge of community 
resources by association to institutionalization and 58.6% were unaware of resources. 
The statistical measurement phi (0) was employed to test the strength of association 
community resource knowledge by institutionalization of the relative. As indicated there 
was no relationship (0=.064) between the two variables. When the chi-square statistical 
test for significance was applied, the null hypotheses was not rejected (p=.54) indicating 
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there was a statistical significant relationship between the two variables at the .05 level of 
probability (See Table 7). 
Research Question 4: Is there a relationship between the diagnosis of Alzheimer's 
disease in the African American population and the access to 
health care by medication. 
The majority of respondents, 61.2% were never given handouts or additional 
information related to compliance or healthcare by obtaining medications. Only 38.8% 
were given handouts and other information related to access to health care (See Table 8). 
The statistical measurement phi (0) was employed to test for the strength of 
association between the access to healthcare and medications and compliance. As 
indicated, there was a weak relationship (0=.266) between the two variables. When the 
chi-square statistical test for significance was applied, the null hypotheses was rejected 
(p=.014) indicating that there was no statically significant relationship between the two 
variables at the .05 level of probability (See Table 8). 
Research Question 5: Is there a significant relationship between caregiver stressors and 
caring for an Alzheimer's relative? 
Respondents reported 47.1% that stress was not involved in caring fro a relative 
with Alzheimer's disease while 52.9% agree that here was stress involved in caring for 
the relative with Alzheimer's disease (See Table 9). 
The statistical measurement phi (0) was employed to test for the strength of 
association between stressors involved in caring for the relative with Alzheimer's 
disease. As indicated there was no relationship (0=.219) between the two variables. 
When the chi-square statistical test for significance was applied, the null hypotheses was 
rejected (p=.043) indicating that there was no statistically significant relationship 
between the two variables at the .05 level of probability. 
Recommendations 
Studies inclusive of African Americans in Alzheimer's research are fiequently 
limited by the lack of access to research and utilization of services. The decision to 
include ethnicities with this growing population is paramount in decreasing the incidence 
in this costly and growing disease. 
As a result of the findings of this study, the researcher is recommending the 
following: 
1. Research should continue and increase the number of African Americans in 
research to increase both internal and external validity of future research projects 
(i.e. becoming more culturally sensitive in recruitment efforts). 
2. Social workers should engage in research to assist and advise policy makers in 
patterns of utilization by the African American population. 
3. Programs should be developed to deal specifically with research findings 
associated with availability, accessibility, acceptability and financial restraints to 
gaining access to services provided for the treatment of Alzheimer's disease. 
4. Schools of Social Work must begin to incorporate studies for the aged, as they 
explore the dynamics of the catastrophic results of overlooking the number three 
(3) disease of the elderly, Alzheimer's disease. 
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5 .  The Social Work Leadership Institute (SWLI) must support policies that cultivate 
leaders to assist with public policies. SWLI must recruit and retain qualified 
social workers in the area of gerontology to effect changes in access to health care 
and services, participation in research by minorities and assist the caregiver with 
community resources. 




Letter to Sadie G. Mayes Nursing Home 
November 14,2007 
Charles Robinson, Jr. CEO 
Sadie G. Mayes 
1 870 Anderson Avenue 
Atlanta Georgia 303 14 
Dear Sir: 
I am a graduate student in the Ph.D. Program at the Whitney M. Young, Jr., 
School of Social Work at Clark Atlanta University. I am presently writing my doctoral 
dissertation on the disproportionately higher incidence of Alzheimer's disease in the 
African American population. I had spoken with Ms. Brooks, in your Human Resource 
Department who referred me to your office to obtain permission for this endeavor. 
I am presently a nursing supervisor in the substance abuse arena in the Ann Arbor 
Michigan area; however my research population will be in the metropolitan Atlanta area 
encompassing Assisted Living facilities and Home Health Care Organization. 
I would appreciate an appointment to discuss this potential research with you. I 
am sending you a proposed Survey Questionnaire for your information. I have also sent 
a copy of my correspondence to Ms. Jocelyn Brantley your Social Worker for her review 
as well. I will be in touch via phone to confirm a date to speak with you. 
Edna Andrews-Benson, Ph.D. Candidate 
Clark-Atlanta University 
cc: Richard Lyle, Chair 
APPENDIX B 
Letter to Staff Builders Home Health Care 
November 14,2007 
Jean Bishop, RN, BSN, Case Manager 
Staff Builders Home Health Care 
9040 Roswell Rd. 
Atlanta, Georgia 303 50 
Dear Madame: 
I am a graduate student in the Ph.D. Program at the Whitney M. Young, Jr., 
School of Social Work at Clark Atlanta University. I am presently writing my doctoral 
dissertation on the disproportionately higher incidence of Alzheimer's disease in the 
African American population. 
I am presently a nursing supervisor in the substance abuse arena in the Ann Arbor 
Michigan area; however my research population will be in the metropolitan Atlanta area 
encompassing Assisted Living facilities and Nursing Homes. 
I would appreciate an appointment to discuss this potential research with you. I 
am sending you a proposed Survey Questionnaire for your information. I will be in touch 
via phone to confirm a date to speak with you. 
Edna Andrews-Benson, Ph.D. Candidate 
Clark-Atlanta University 
cc: Richard Lyle, Chair 
APPENDIX C 
Letter to Ashton Hall Assisted Living Facility 
November 14,2007 
Ashton Hall Assisted Living facility 
1 155 Lawrenceville Hwy. 
Lawrenceville, Georgia 30044 
Dear Madame: 
I am a graduate student in the Ph.D. Program at the Whitney M. Young, Jr. 
School o Social Work at Clark Atlanta University. I am presently writing my doctoral 
dissertation on the disproportionately higher incidence of Alzheimer's disease in the 
African American population. 
I am presently a nursing supervisor in the substance abuse arena in the Ann Arbor 
Michigan area; however my research population will be in the metropolitan Atlanta area 
encompassing Assisted Living facilities and Nursing Homes. 
I would appreciate an appointment to discuss this potential research with you. I 
am sending you a proposed Survey Questionnaire for your information. I will be in touch 
via phone to confirm a date to speak with you. 
Edna Andrews-Benson, Ph.D. Candidate 
Clark-Atlanta University 
cc: Richard Lyle, Chair 
APPENDIX D 
Survey Questionnaire 
Alzheimer's Caregiver Questionnaire 
Dear Caregiver: 
I am a student in the Ph.D. Program at the Whitney M. Young, Jr., School of 
Social Work at Clark Atlanta University. I invite you to participate in a questionnaire 
related to Alzheimer's disease. The questionnaire will take between 5-10 minutes to 
complete. The purpose of the study is to learn more about the diagnosis of Alzheimer's 
disease in the Afiican American population. The findings will be used in an analysis for 
my dissertation. I would appreciate your cooperation. To maintain confidentiality please 
do not place your name on the questionnaire answer sheet. Again thank you for your 
time and cooperation. 
Edna Andrews-Rose 
If your family member is deceased please answer on the status prior to 
death.////////////////////////////////////////////////////////////////////////////////////////////////////////////////////// 
Section I Demographic Information 
Place an (X) next to the appropriate item. Choose only one answer for each question, 
1.  My family member is: 
1) M a l e  2) F e m a l e  
2. My family members age is: 
1) 60-70 2) - 7 1-80 3) 8 1 -up 4) - deceased 
3. Racial category of my family member is: 
Black 1) - 2) White 3) - Hispanic 4) O t h e r  
Section I1 Socioeconomic Status: 
4. My family member s' yearly income islwas: 
1) - under 10,000 2) - $10,001-20,000 
3) - 20,001-30,000 4) 30,001-40,000 5) - over 40,000 
5. My family members7 occupation prior to retirement: 
1) - Executive 2) Professional 3) Technica l  4) S e r v i c e  Organization 
5) M a c h i n i s t  6) S e r v i c e  Occupation 7) H e l p e r /  Laborer 8) Transportat ion 
9) - Clerical 
6. My family members' educational level is: 
1) - Elementary 2) - Some High School 3) H i g h  School Grad 
4) -Vocational School 5) S o m e  College 6) - College Graduate 
7) - Graduate School 8) Masters 9) -Ph..D. 
APPENDIX D (continued) 
Section 111: Participation in Research 
The following statements are designed to get your opinion on several variables associated 
with Alzheimer's disease. Write the appropriate nurnber (1 thru 4) in the blank space in 
front of each statement on the questionnaire. Please respond to all questions. 
l=Stronglv Disagree 2=Disagree 3= Avree - 4=Stronglv Agree 
7.. Risk for research is shared by all. - 
8.. Risk for research is not shared equally by all.. - 
9. Minorities bear much of the risk of research. - 
10. I am aware of research related to Alzheimer's disease.. - 
Section IV: Caregiver Knowledge 
Respond to the following questions by checking either Yes or No regarding you or your 
family member. 
Yes--- No - 1 1. Have you ever been asked to participate in research for Alzheimer's disease? 
Y e s  No - 12. Would you be willing, if asked, to allow you or your family member to participate in 
Alzheimer's research? 
Yes No - 13 .. Are you aware of the Tuskegee research study on Syphilis? 
Y e s  No 14. Are you aware of the thee stages of Alzheimer's disease? 
Yes N o  -15.. Are you aware of any community resources to assist with the needs of your family 
member? 
Yes - No - 16. Were you given handouts or written material at the time of the diagnosis of 
Alzheimer's? 
Yes - No - 17. Are there any other family members who help with the care of your family member? 
Yes N o  18. Does your family member presently reside in a nursing home or assisted living 
facility? 
19. If yes to the above question, how long did the family member reside with you prior to 
placement? - 1-3 years - 4-6 years - 7- 9 years - 10 years or greater 
Section V: Access to Health care 
Yes N o  -20. Does you family member presently take medications for Alzheimer's? 
Yes - No - 2 1. Were you asked if medication cost was a barrier to compliance? 
Yes - No - 22.. Have you ever received samples of medications used in the treatment of Alzheimer's? 
23. If you answered "Yes" to # 20 who pays for the medication? 
(1) Medicaid - (2) Out of pocket - (3) By Nursing homelassisted living facility 
24. what medications does your family member presently take for Alzheimer's condition? 
- (1) Exelon - (2) Aricept -(3) Remeron -(4) Namenda ( 5 )  Cognex -(6)other 
- (7) None 
APPENDIX D (continued) 
Section VI: Caregiver Stressors 
For the following questions right the appropriate response (1 thru 4) in the blank space in 
fiont of the statement or question. Please respond to all questions. 
I= Stronglv Disagree 2= Disagree 3= Agree 4= Strongly A~ree  
25.. Do you feel because of the time you spendlspent with your relative, you do not/did not have - 
enough time for yourself? 
26. Do you feel strained when around your relative? - 
27. Do you feel that your health has suffered because of your involvement with your relative? - 
28. Do you feel that you will be unable to care for your relative very much longer? - 
29.. Do you feel uncertain about what to do for your relative? - 
30.. Do you feel embarrassed by your relatives' behavior at times? - 
Once again I thank you for your par.ticipating in this research endeavor. 
APPENDIX E 
SPSS Program Analysis 
TITLE 'ALZHEIMER CAREGIVER QUESTIONNAIRE'. 


































ID 'Case Number' 
GENDER 'Q1 Gender of my family member' 
AGEGRP 'Q2 Age of my family members' 
ETHNIC 'Q3 Racial category of my family member' 
INCOME 'Q4 Income of my family member' 















'Q5 Occupation prior to retirement of my family member' 
'Q6 Highest educational level of my family member' 
'(27 Risk for research is shared by all' 
'Q8 Risk for research is not shared equally by all' 
'Q9 Minorities bear much of the risk of research' 
'Q10 I am aware of research related to Alzheimer disease' 
'(211 Have you ever been asked to participate in research for 
Alzheimer disease' 
'Q12 Would you allow a family member to participate in 
Alzheimer research' 
'Q13 Are you aware of the Tuskegee research study on 
Syphillis' 
'914 Are you aware of the three stages of Alzheimer disease' 
'Q15 Are you aware community resources to assist with the 
needs of a family member' 
'Q16 Were you given written handouts at the time of the 
diagnosis of Alzheimer' 
'Q17 Are there any other family members who help with the 
care of your family member' 
'918 Does your family member presently reside in a nursing 
home or assisted living facility' 
'Q19 How long did the family member reside with you prior to 
placement' 
'Q20 Does a family member presently take medications for 
Alzheimer disease' 
'Q21 Were you asked if medication cost was a barrier to 
compliance' 
'922 Have you ever received samples of medication used in 
the treatment of Alzheimer' 
'923 Who pays for the medication' 
'924 What medications do your family member presently take 
for Alzheimer' 
'Q25 Because of the time you spend with relatives you do not 
have enough time for yourself' 
'926 Do you feel strained when aroung your relatives' 
'927 Do you feel that your health has suffered because of 
your involvement with relatives' 
'Q28 Do you feel that you will be unable to care for your 
relative very much longer' 
'Q29 Do you feel uncertain about what to do for your 
relative' 
'(230 Do you feel embarrassed by your relatives behavior at 
times ' . 
















1 'Under $10,000' 
2 '$10,001 - 20,000' 
3 '$20,001 - 30,000' 
4 '$30,001 - 40,000' 





4 'Service Organization' 
5 'Mechinist' 






2 'Some High School' 
3 'High School Grad' 
4 'Vocational School' 
5 'Some College' 
6 'College Grad' 
7 'Graduate School' 
8 'Masters Degree' 
9 'Doctoral Degree1/ 
RISKYES 
1 'Strongly Disagree' 
2 'Disgree' 
3 'Agree' 
4 'Strongly Agree1/ 
RI SKNO 
1 'Strongly Disagree' 
2 'Disgree' 
3 'Agree' 
4 'Strongly Agree1/ 
APPENDIX E (continued) 
MINORITY 
1 'Strongly Disagree' 
2 'Disgree' 
3 'Agree' 
4 'Strongly Agree1/ 
RESEARCH 
1 'Strongly Disagree1 
2 'Disgree' 
3 'Agree' 











































APPENDIX E (continued) 
STRESS1 
1 'Strongly Disagree' 
2 'Disgree' 
3 'Agree ' 
4 'Strongly Agreef/ 
STRESS2 
1 'Strongly Disagree' 
2 'Disgree' 
3 'Agree' 
4 'Strongly Agreef/ 
STRESS3 
1 'Strongly Disagree' 
2 'Disgree' 
3 'Agree' 
4 'Strongly Agreer/ 
STRESS4 
1 'Strongly Disagree' 
2 'Disgree' 
3 'Agree ' 
4 'Strongly Agreef/ 
STRESS5 
1 'Strongly Disagree' 
2 'Disgree' 
3 'Agree' 
4 'Strongly Agreef/ 
STRESS6 
1 'Strongly Disagree' 
2 'Disgree' 
3 ' Agree' 
4 'Strongly Agreev/. 
MISSING VALUES 
GENDER AGEGRP ETHNIC INCOME OCCUPAT EDUCA RISKYES 
RISKNO MINORITY RESEARCH KNOW1 KNOW2 KNOW3 KNOW4 
KNOW5 KNOW6 KNOW7 KNOW8 KNOW9 ACCESS1 ACCESS2 ACCESS3 ACCESS4 ACCESS5 
STRESS1 STRESS2 STRESS3 STRESS4 STRESS5 














APPENDIX E (continued) 





























RECODE INCOME (1 THRU 3.99=3) (4 THRU 5.99=4). 
RECODE RISKYES RISKNO MINORITY RESEARCH (1 THRU 2.99=2) (3 THRU 4.99=3). 
RECODE STRESS1 STRESS2 STRESS3 STRESS4 STRESS5 STRESS 6 (1 THRU 2.99=2) 
(3 THRU 4.99=3). 
STRESS6 (0). 
FREQUENCIES 
/VARIABLES GENDER AGEGRP ETHNIC INCOME OCCUPAT EDUCA 
RISKYES RISKNO MINORITY RESEARCH KNOW1 KNOW2 KNOW3 KNOW4 
KNOW5 KNOW6 KNOW7 KNOW8 KNOW9 ACCESS1 ACCESS2 ACCESS3 
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